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The Finnish Intensive Care 
Consortium co-ordinates a 
benchmarking programme in 
intensive care. The Consortium 
comprises all general adult intensive 
care units in all main Finnish 
hospitals. For every admission 
to these units, data on severity 
of illness, intensity of care and 
outcomes are documented in the 
Consortium’s database. Data from 
this database were used for this 
study. This dissertation presents 
new information about the outcomes 
of Finnish intensive care, prognostic 
factors and factors affecting the 
calculation of severity of illness-
adjusted mortality rates.
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ABSTRACT 
 
For patients treated in an intensive care unit (ICU), the main factors determining the risk of 
death are the severity of the acute illness, age and previous state of health. The aims of this 
study were to explore the associations between some controversial factors and mortality 
and to quantify the changes in hospital mortality of ICU patients in Finland in recent years. 
The Finnish Intensive Care Consortium is a body co-ordinating a national benchmarking 
programme in intensive care. The Consortium comprises all general adult ICUs in all main 
Finnish hospitals; a few highly specialised ICUs are not involved. For all admissions to the 
participating ICUs, data on characteristics and severity of illness, intensity of care and 
outcomes are documented in the Consortium’s database. Data from this database were 
used for this study. In five substudies, the number of patients studied varied from 3958 to 
85 547. In addition, data from a cohort study on patients with severe sepsis, the Finnsepsis 
study, were used to investigate the relationship between hospital size and patient outcomes 
in this group. The number of patients in this substudy was 452. 
During the years 2001-2008, the mean hospital mortality rate for Finnish ICU patients 
was 18.4%. Compared to results from international studies on patient populations with 
comparable severity of illness, outcomes of Finnish intensive care are good. Moreover, the 
outcomes further improved during the study period.  
Hospital mortality increased with increasing age, being close to 30% in patients aged 
over 80 years. Mortality was particularly high in the oldest patients admitted to ICUs for 
non-surgical reasons. Over 60% of all ICU patients were males, and male gender 
contributed to the risk of poor outcome among the oldest patients. The ageing of the 
population will most probably increase the demand for intensive care in the near future. 
There was a high amount of patients needing intensive care for respiratory failure in the 
winter season and excess mortality in winter. The severity of illness-adjusted risk of death 
during the holiday season in July was similar to that in other months.  
For surgical patients with severe sepsis, treatment in small ICUs was associated with 
increased mortality. For patients treated in ICUs after resuscitation from out-of-hospital 
cardiac arrest, hospital mortality decreased concurrently with the introduction of 
therapeutic hypothermia for post-resuscitation care. 
Improved data completeness and automation of data collection with a clinical 
information system increase severity-of-illness scores and decrease severity-adjusted 
mortality rates. This should be taken into account in benchmarking programmes if some 
ICUs use technology for automatic data collection and others do not.  
 
National Library of Medicine Classification: WA 900, WC 240, WX 218 
Medical Subject Headings: Intensive care; Treatment Outcome; Hospital Mortality; Risk Factors; Sex Factors; 
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TIIVISTELMÄ 
 
Sairauden vaikeusaste sekä potilaan ikä ja aikaisempi terveydentila ovat tärkeimmät 
tehohoidossa olevan potilaan kuolemanvaaraan vaikuttavat tekijät. Tämän tutkimuksen 
tavoitteena oli selvittää tehohoitopotilaiden kuolleisuuden kehitys Suomessa viime vuosina 
ja tutkia tiettyjen kiistanalaisten tekijöiden yhteyttä kuolemanvaaraan. 
Suomen Tehohoitokonsortio on teho-osastojen yhteenliittymä, joka ohjaa tehohoidon 
kansallista vertaisarviointihanketta. Konsortioon kuuluvat kaikkien suomalaisten yliopisto- 
ja keskussairaaloiden kaikki yleisteho-osastot. Jotkin pitkälle erikoistuneet teho-osastot 
eivät ole tässä hankkeessa mukana. Konsortioon kuuluvien osastojen kaikista hoitojaksoista 
tallennetaan sairauden laatua ja vaikeusastetta, annettua hoitoa ja sen lopputulosta 
koskevat ydintiedot kansalliseen laatutietokantaan. Tämän tietokannan tietoja käytettiin 
tässä tutkimuksessa. Viidessä osatutkimuksessa tutkittujen potilaiden määrä oli välillä 3958 
– 85 547. Yhdessä osatutkimuksessa käytettiin lisäksi kansallisen Finnsepsis-tutkimuksen 
tietoja tutkittaessa sairaalan koon vaikutusta vaikeaa sepsistä sairastavien potilaiden 
hoitotuloksiin. Tässä osatutkimuksessa potilaiden määrä oli 452. 
Vuosina 2001-2008 keskimäärin 18,4 % teho-osastojen potilaista kuoli teho-osastolla tai 
tehohoidon jälkeen saman sairaalahoitojakson aikana. Kuolleisuus oli selvästi alhaisempi 
verrattuna sellaisiin kansainvälisiin tutkimuksiin, joissa potilasaineiston keskimääräinen 
sairauden vaikeusaste oli samantasoinen. Hoitotulokset paranivat edelleen tutkimusjakson 
aikana. 
Kuolleisuus lisääntyi iän myötä ja oli liki 30 % yli 80-vuotiailla. Kuolleisuus oli erityisen 
suurta niiden iäkkäimpien potilaiden ryhmässä, joiden tehohoidon tarpeen syynä oli muu 
kuin kirurginen sairaus. Miespuolisten potilaiden osuus kaikista tehohoitopotilaista oli yli 
60 %. Iäkkäimpien potilaiden ryhmässä miessukupuoli lisäsi kuolemanvaaraa. Väestön 
ikääntyminen lisännee tehohoidon kysyntää lähitulevaisuudessa. 
Hengitysvajauksen vuoksi tehohoitoa tarvinneiden määrä oli suurempi talvella kuin 
muina vuodenaikoina. Kuolleisuuskin oli suurempi talvella. Sairauden vaikeusasteen suh-
teen korjattu kuolemanvaara ei ollut heinäkuussa sen suurempi kuin muina kuukausina. 
Vaikeaa sepsistä sairastavien kirurgisten potilaiden kuolleisuus oli suurempi pienissä 
kuin suurissa sairaaloissa. Sydämenpysähdyksen ja elvytyksen jälkeen teho-osastoilla 
hoidettujen potilaiden kuolleisuus laski samanaikaisesti, kun viilennyshoito otettiin 
käyttöön osana tämän potilasryhmän hoitoa. 
Tiedonkeruun tarkentuminen ja sen automatisointi kliinistä tietojärjestelmää käyttämällä 
lisäävät mitattua sairauden vaikeusastetta, mikä johtaa laskennallisen vakioidun 
kuolleisuussuhteen laskuun. Tämä seikka tulisi ottaa huomioon vertaisarviointihankkeissa 
silloin, kun vain osa yksiköistä käyttää teknologiaa automaattista tiedonkeruuta varten. 
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hypotermia; tietotekniikka; automaatio  
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1 Introduction  
In the summer of 1952, a polio epidemic was raging in Copenhagen, Denmark. The prognosis of 
patients with paralysis involving respiratory and bulbar muscles seemed to be almost hopeless, 
as 27 of the first 31 patients (87%) with respiratory insufficiency died, most of them within three 
days of hospital admission (Lassen 1953). When a 12-year-old girl was desperately ill, gasping 
for air and apparently not far from dying from respiratory failure, the anaesthesiologist Bjørn 
Ibsen was called to help. At that time, manual positive pressure ventilation with an anaesthetic 
bag had already been used for years in operating theatres. Ibsen attempted to save the girl’s life 
with manual bag ventilation via a tracheotomy and with appropriate sedation to cope with 
bronchospasm – and succeeded (Wackers 1994, Trubuhovich 2004a, Trubuhovich 2004b). 
According to Ibsen himself, the girl who had been cyanotic, sweating and drowning in her own 
secretions, “became warm, dry and pink – a condition which always makes an anaesthetist happy” 
(Ibsen 1954). On Ibsen’s initiative, this technique was brought into large scale use on polio 
patients with respiratory insufficiency, and mortality rates declined dramatically (Lassen 1953, 
Trubuhovich 2004b). It became clear that positive-pressure ventilation could help most polio 
patients with paralysis of respiratory muscles to survive until recovery started and they 
regained enough muscle strength for sufficient spontaneous breathing. For some of the over 250 
manually ventilated patients, this treatment was needed for several months (Lassen 1953, 
Berthelsen et al. 2007). 
 Bjørn Ibsen was not the first one to successfully use positive-pressure ventilation outside 
operating theatres, not even on a large scale. In 1948-1949, Albert Bower and V. Ray Bennett 
were faced with a large number of polio patients with respiratory insufficiency in Los Angeles, 
USA (Trubuhovich 2007). Tank respirators providing ventilatory support with intermittent 
negative pressure were in use, but in many cases they turned out to be ineffective. Bower and 
Bennett converted the negative pressure ventilation machine into one that could supply 
intermittent positive pressure ventilation and achieved remarkably better survival rates than in 
patients previously treated with negative pressure ventilation alone. Before the historic events 
in Copenhagen in 1952, Ibsen was aware of the success that Bower and Bennett had achieved 
earlier using positive pressure ventilation (Wackers 1994). 
However, Ibsen’s notable achievements were not limited to his contribution in treating polio 
patients. In 1953, he utilised the experience gained from these patients and from organising 
their treatment when he created a unit that is generally acknowledged as the first 
multidisciplinary intensive care unit in the world (Berthelsen and Cronqvist 2003, Reisner-
Sénélar 2011). Postoperative recovery rooms for surgical patients had existed before, but usually 
patients were treated in such units only for a short time post-operatively, until the effects of 
anaesthesia had vanished. Regarding critically ill medical patients, aggressive treatment was 
generally not considered useful. Ibsen refused to accept the prevailing fatalism and chose an 
active and optimistic strategy, paving the way for a new branch in medicine – intensive care 
medicine (Berthelsen and Cronqvist 2003). 
Polio epidemics struck Finland too, until vaccination programmes eradicated the disease in 
the early 1960s. The largest epidemic occurred in 1954. At that time, the Aurora hospital in 
Helsinki was rather well prepared. Previous experiences using cuirass respirators (based on 
negative pressure) had been very disappointing, the mortality rate being roughly 90%, and 
from the autumn of 1953 the hospital’s strategy was to use positive pressure ventilators that had 
been hurriedly bought (Pettay 1955a, 1955b). During the years 1954-1960, 372 patients with 
paralytic polio were treated in the Aurora hospital. 100 patients needed ventilator treatment; a 
tracheotomy was performed on all of these. Though the majority of the patients needed 
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ventilatory assistance for several months, the one-year mortality was only 16% (Pettay et al. 
1964). One patient even gave birth to a healthy baby boy with a forceps-assisted delivery while 
being treated with a ventilator (Pettay 1955a). After a mean follow-up time of 5.7 years, 74 of the 
100 patients were still alive, though 14 of them remained dependent on the ventilator (Pettay et 
al. 1964).  
The ventilator treatment of polio patients suffering from respiratory insufficiency in the 
1950s was organised in a dedicated department with special equipment and specially trained 
personnel, and severely ill patients arriving from long distances were admitted (Pettay et al. 
1964); all these features are characteristic of intensive care. However, the terms “intensive care” 
or “intensive care unit” were not used at that time. Nor were they officially used for the post-
operative units for neurosurgical or cardiac surgical patients in the late 1950s and early 1960s 
(Klossner 2002, Jalonen 2006, Tammisto and Tammisto 2009). Finland’s first two intensive care 
units, called by that name, were opened in January 1964 in Kuopio and Helsinki (Klossner 2002, 
Tammisto and Tammisto 2009). There is a still unresolved debate about which one was first. 
For decades now, the intensive care unit (ICU) has been one of the cornerstones at an acute 
care hospital. An ICU is an area in a hospital that is staffed with specially trained personnel and 
is dedicated to the treatment of critically ill patients who have physiological disorders that are 
acute and life-threatening but still potentially reversible. The ICU provides continuous 
monitoring and high-intensity care to support or replace failing physiological functions 
(Moreno et al. 2010a).  
By the mid-1980s, clinical experience and research on outcomes from intensive care had 
revealed the major determinants of short-term prognosis of ICU patients, even to the extent that 
their relative contributions could be written into a mathematic formula (Knaus et al. 1981, 
Knaus et al. 1985). The main factors affecting the risk of in-hospital death are age, previous 
health status (namely, the presence or absence of severe co-morbidities) and the severity of the 
acute illness, as reflected by the degree of abnormality in the values of essential physiological 
measurements. In addition, the underlying diagnosis is important: some conditions have a good 
short-term prognosis even when the values of many physiological measurements are severely 
abnormal (e.g. diabetic ketoacidosis), whereas others have a rather gloomy prognosis (e.g. 
admission after resuscitation from cardiac arrest). Among surgical patients, admissions after 
emergency operations are associated with worse outcomes than admissions after elective 
surgery (Knaus et al. 1985).  
In addition to the well-known major factors influencing the risk of death, many other factors 
may be of importance. However, the scientific literature is inconclusive for many of these. It has 
been known for long that gender affects the susceptibility to many diseases: in 1934, Allen 
concluded from his large study that “among males there is a higher incidence of most diseases which 
might permanently influence health or endanger life” (Allen 1934). Yet, it is unclear whether gender 
has any independent effect on the patient’s ability to recover from critical illness. According to 
some authors, men fare better than women (Kollef et al. 1997); according to others, male gender 
is associated with worse outcomes (Moss and Mannino 2002). Some authors have raised the 
question that there might be a gender bias in the allocation of resources (Valentin et al. 2003, 
Tilford and Parker 2003). 
In the general population, mortality from many conditions is increased in winter (Sheth et al. 
1999, Olson et al. 2009). We do not know whether there is a seasonal variation affecting 
outcomes from intensive care. Nor do we know if a “July phenomenon”, i.e. substandard 
quality of care in July due to staff transition (Inaba et al. 2010), exists in intensive care. There is 
also uncertainty about the impact of hospital volumes on patient outcomes. For elective high-
risk surgery the general rule seems to be the bigger the better (Birkmeyer et al. 2002), but does 
this apply to intensive care?  
Even the impact of chronological age is somewhat controversial. Increasing age is 
indisputably associated with increased risk of death, and in practice old age is one of the factors 
associated with refusal of ICU admission (Joynt et al. 2001, Garrouste-Orgeas et al. 2009). 
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However, many authors have with good reason claimed that age alone is not a good predictor 
of outcome; premorbid functional status and the severity of acute illness are mainly responsible 
for the prognosis of the elderly patient (de Rooij et al. 2005, Arsura 2006). Even so, writing 
evidence-based recommendations about which elderly patients will benefit from ICU care and 
should thus be admitted has been impossible so far, because we still know too little about the 
outcomes of intensive care of the elderly (Boumendil et al. 2007). This question is of paramount 
importance, as there will be an enormous increase in the number of elderly people during the 
next 20 years (Flaatten 2007). 
Two randomised controlled trials showed that mild therapeutic hypothermia improves the 
chance of survival of patients resuscitated from out-of-hospital cardiac arrest with an initial 
cardiac rhythm of ventricular fibrillation (Hypothermia after Cardiac Arrest Study Group 2002, 
Bernard et al. 2002). However, the inclusion criteria in these studies were strictly defined and 
were met only by a minority of resuscitated patients. It is not known whether the use of 
hypothermia can bring a major survival benefit also in real life, i.e. outside the context of a 
controlled clinical trial. 
Patient mortality, adjusted for disease characteristics and severity, is a commonly used 
marker of ICU performance. Comparing that performance with a specified standard, referred to 
as benchmarking, has become popular in recent years (Moreno et al. 2010b). There is, however, 
little evidence that benchmarking results in better outcomes (Woodhouse et al. 2009). Moreover, 
differences in physiological measurements for severity-of-illness calculations may alter 
predicted probabilities of death and thus change standardised mortality ratios, causing severe 
bias in the pertinent figures in benchmarking. Studies on small patient populations have clearly 
shown that both the use of a clinical information system that automatically records physiologic 
data and increasing the frequency of laboratory tests lead to higher severity-of-illness scores, 
higher predicted probabilities of death and lower standardised mortality ratios (Bosman et al. 
1998, Suistomaa et al. 2000). We do not know to what extent widespread automation of data 
collection in a large group of ICUs would affect these figures. 
The aim of this study was to shed more light on these controversial issues. The study data 
were derived from the large database of the Finnish Intensive Care Consortium, which is a body 
co-ordinating a quality assurance and benchmarking programme. Since 2007, the Consortium 
has included all general adult ICUs in all the main Finnish hospitals; a few highly specialised 
ICUs are not involved. The database gathers data from every ICU admission to the units 
participating in the Consortium. In addition, data from a prospective cohort study on patients 
with severe sepsis, the Finnsepsis study (Karlsson et al. 2007), were used in the present study to 
investigate the relationship between hospital size and patient outcomes in this group. 
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2 Review of the Literature  
2.1 MAJOR FACTORS AFFECTING THE RISK OF DEATH OF INTENSIVE CARE 
PATIENTS 
The characteristics and severity of the acute illness, the patient’s age and the presence or 
absence of severe co-morbidities are the most important determinants of the short-term 
prognosis (risk of death during present hospitalisation) of ICU patients. Several severity-of-
illness scoring models that take into account the major prognostic factors and quantify the 
severity with a points-score have been developed. The most commonly used models are 
APACHE II (Acute Physiology and Chronic Health Evaluation II) (Knaus et al. 1985) and SAPS 
II (Simplified Acute Physiology Score II) (Le Gall et al. 1993). The newest updated versions of 
these models are called APACHE IV (Zimmerman et al. 2006) and SAPS 3 (Metnitz et al. 2005, 
Moreno et al. 2005). The essential prognostic factors according to the models SAPS II, SAPS 3 
and APACHE IV are presented in Table 1.  
 
Table 1. Major factors that independently affect the short-term prognosis (risk of death during 
present hospitalisation) of patients treated in intensive care units.  
 
Factor Effect 
Age After the age of 40 years, increasing risk with increasing age. 
Chronic diseases AIDS, cirrhosis of liver, haematological malignancy, metastatic cancer and severe 
heart failure (NYHA IV) strongly increase the risk; previous immunosuppressive 
therapy has a smaller but still significant effect. 
Type of admission Lowest risk for patients admitted for post-operative care after scheduled surgery; 
considerably poorer prognosis for medical patients (no surgery done) and for 
emergency surgical patients. 
Values of   
physiological 
measurements 
Abnormal values of the following measurements are associated with increased 
risk; the more abnormal the value, the higher the risk:  
Glasgow Coma Score reflecting level of consciousness, heart rate, systolic or 
mean blood pressure, PaO2/FIO2 ratio reflecting severity of oxygenation 
impairment, body temperature, urinary output, blood haematocrit, white blood 
cell count and platelet count, blood pH and concentrations of bicarbonate, urea 
and creatinine, sodium, potassium, albumin and bilirubin.  
Diagnostic group Crude mortality rates are particularly high (over 40%) in the following groups: 
post cardiac arrest, cardiogenic shock, hepatic failure, severe sepsis of 
gastrointestinal or pulmonary origin. 
After adjustment for other factors, the following major diagnostic categories are 
the strongest independent predictors of outcome: 
Of non-operative diagnoses, the highest risk of death is associated with the 
following: pulmonary fibrosis, parasitic / fungal pneumonia, respiratory cancer, 
intracerebral haemorrhage, subarachnoid haemorrhage, gastrointestinal 
ischaemia, post cardiac arrest, cardiogenic shock. Of post-operative diagnoses, 
the highest risk of death is associated with the following: head trauma, non-
traumatic intracranial haemorrhage, gastrointestinal ischaemia. 
The following diagnoses are the strongest independent predictors of good 
prognosis: diabetic ketoacidosis, drug overdose, acute asthma. 
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The severity of the acute illness is reflected by the abnormality of the values of the essential 
physiological variables that are presented in table 1. In general, the more abnormal the value, 
the more points are given to the severity score, and the higher is the predicted risk of in-hospital 
death. However, the relationship between the level of abnormality in physiological values and 
the associated increase in risk is generally not linear. In addition, the relative weights of the 
different components of the severity models vary. For example, the independent effect of 
abnormal sodium or potassium values is relatively small, whereas a severely impaired level of 
consciousness (Glasgow Coma Score < 6), severe hypotension (systolic blood pressure < 70 
mmHg) or severely impaired oxygenation (PaO2/FIO2 ratio < 100 mmHg) all substantially 
increase the risk of death. A very low platelet count (< 20 x 109/l) strongly increases the risk, as 
does an age of over 80 years.  
In each of these models, the severity-of-illness score can be converted by a mathematical 
formula into a predicted probability of in-hospital death. The scores or probabilities are not 
primarily intended to guide decision-making regarding individual patients but to serve as tools 
in stratifying patient groups according to severity of illness and in measuring ICU performance. 
The use of the prediction models for benchmarking purposes and the SAPS II scoring system 
are described in chapter 2.7 of this thesis. 
The score given by the commonly used severity models is based on information that is 
available at the beginning of the intensive care period. The APACHE models and SAPS II take 
into account the worst value of each physiological measurement during the first 24 hours after 
ICU admission. SAPS 3 uses a more narrow time window that starts one hour before and ends 
one hour after ICU admission. These models therefore quantify the severity of illness only at the 
beginning of the ICU stay. The predictive ability of the models weakens as the length of stay in 
the ICU increases, and for patients with lengths of ICU stay of over seven days, the predictive 
ability is poor (Suistomaa et al. 2002). 
The SOFA score is a system describing the presence and severity of dysfunction or failure of 
essential organ systems. The acronym originally stood for “Sepsis-related Organ Failure 
Assessment” (Vincent et al. 1996). However, as the system is not specific to septic patients, the 
acronym was soon taken to refer to “Sequential Organ Failure Assessment” (Vincent et al. 1998). 
SOFA evaluates the function of six organ systems: respiration, coagulation, liver, cardiovascular 
function, central nervous system, and renal function. For each organ system, a score of 0 
(reflecting normal function) to 4 (most abnormal) is given.  The worst value for each day is 
recorded for each organ system. The sum of the organ-specific scores is the SOFA score. The 
score can be used not only at the beginning of the treatment period but also as a continuous 
measurement of the severity of organ dysfunctions. The SOFA scoring system is presented in 
Table 2.  
The SOFA score differs from the commonly used prediction models in several ways: Firstly, 
SOFA was designed not to predict outcome but to describe quantitatively and objectively the 
degree of organ dysfunction over time both in individual patients and in groups of patients 
(Vincent et al. 1996). Secondly, SOFA was not based on mathematical modelling but was 
created by a group of experts in a consensus conference. Nevertheless, studies have shown that 
high SOFA scores for any individual organ system as well as high total scores are associated 
with increased mortality. The mortality rate was > 90% among patients whose maximum SOFA 
score (the highest score during the ICU stay) was > 15, but well below 10% among the patients 
whose maximum SOFA score was < 7 (Vincent et al. 1998). Several other SOFA-based prediction 
models have been developed and they work rather well (Minne et al. 2008). Models that 
combine sequential SOFA scores with the APACHE II/III or SAPS II models have shown 
particularly good prognostic performance (Minne et al. 2008). 
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Table 2. The SOFA (Sequential Organ Failure Assessment) scoring system  
 
SOFA score 1 2 3 4 
Respiration 
(PaO2/FIO2, mmHg) < 400 < 300 < 200 
a < 100 a 
Coagulation 
(Platelets, x 109/l)  < 150 < 100 < 50 < 20 
Liver 
(Bilirubin, µmol/l) 20-32 33-101 102-204 > 204 
Cardiovascular 
(Hypotension or dose of 
vasoactive medication) 
MAP < 70 
mmHg 
Dopamine ≤ 5 or 
dobutamine (any 
dose) b 
Dopamine > 5 or 
epinephrine ≤ 0.1 
or norepinephrine 
≤ 0.1 b 
Dopamine > 15 or 
epinephrine > 0.1 
or norepinephrine 
> 0.1 b 
Central nervous system 
(Glasgow Coma Score) 13-14 10-12 6-9 < 6 
Renal 
(Creatinine, µmol/l, or 
urine output)  110-170 171-299 
300-440 or    
< 500 ml/day 
> 440 or 
< 200 ml/day 
a With respiratory support; b adrenergic agents administered for at least 1 h (doses are in µg/kg/min);  
MAP, mean arterial pressure  
 
Intensive care units mainly treat patients who are critically ill but who are still considered to 
have a reasonable chance of recovery. Patients who are in the terminal phase of an incurable 
disease or who are otherwise estimated to be too sick to benefit from intensive care are seldom 
admitted to ICUs (Garrouste-Orgeas et al. 2005, Moreno and Rhodes 2010c). Thus, the 
prognostic factors presented in this chapter apply to a highly selected group of patients, as the 
patients treated in an ICU are not a representative sample of the patients in the hospital.  
Another important thing to remember is that, although some factor might not appear to be 
associated with outcome among those patients who have already been admitted to the ICU, that 
factor may well be the real reason for the critical condition that requires intensive care (and, if 
the patient dies, the real cause of death). For example, alcohol use is very often the reason for 
the need of intensive care and the cause of death for some of these patients. Yet, within the 
group of ICU patients, alcohol use does not seem to be a predictor of death, as there is no 
difference in mortality between alcohol-related admissions and other admissions (Uusaro et al. 
2005). Thus, it is not only important to know what factors have prognostic significance among 
patients who are treated in ICUs but also to find the factors that lead to the need for intensive 
care, and this may not be possible by studying only ICU patients. 
In addition to the indisputable major determinants of short-term prognosis, many other 
factors may have some impact. The following chapters will present a review of the current 
knowledge regarding some of these factors.     
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2.2 INFLUENCE OF GENDER ON OUTCOMES FROM TRAUMA AND CRITICAL 
ILLNESS 
2.2.1 Animal Studies 
Sex hormones affect immune functions and the ability to recover from trauma: Administration 
of estradiol to male mice improves immune responses after haemorrhagic trauma (Knöferl et al. 
2000), while an ovariectomy in female mice before trauma and haemorrhagic shock depresses 
immune functions (Knöferl et al. 2002). Estradiol administration to male rats improves 
cardiovascular and hepatocellular functions after trauma (Mizushima et al. 2000). In contrast, 
testosterone treatment of female mice causes immune depression after haemorrhagic shock 
(Angele et al. 1998), and castration of male animals before trauma and haemorrhage prevents 
depression of immune functions (Wichmann et al. 1996a) and improves myocardial function 
(Remmers et al. 1998). 
These results can be summarised as follows:  following trauma haemorrhage, female sex 
hormones seem to enhance immune functions and improve cardiovascular and hepatocellular 
functions, while male sex hormones seem to be responsible for immunosuppression and 
depression of myocardial function. This explains the findings of improved immune responses 
in females and decreased responses in males following haemorrhagic shock. As a consequence, 
females should be able to immunologically tolerate trauma and major blood loss better than 
males (Wichmann et al. 1996b). Female mice also seem to be able to tolerate a septic challenge 
better than male mice, which has been attributed either to the presence of beneficial female sex 
hormones or the absence of immune-depressive concentrations of testosterone (Zellweger et al. 
1997).    
2.2.2 Human Studies 
 
Incidence of diseases 
Already in the 1930s, careful attention was paid to the fact that for many serious diseases the 
gender distribution of patients did not match that of the general population. Allen made a large 
study on the incidence of severe diseases that affect structures common to both sexes (Allen 
1934). He noticed that for most serious illnesses of the digestive tract, the lungs and respiratory 
tract, as well as the blood vessels and heart, males were affected more frequently than females. 
Diseases of the gallbladder, obesity, arthritis and “hysteria” were among the few diseases that 
were more common in females. As a result, death rates for men were higher than those for 
women in all age groups except among persons aged 20 to 34 years, when mortality of females 
was higher, apparently due to deaths associated with childbirth. Allen pointed out that the 
mortality of males was higher than that of females already during intra-uterine life and during 
the very first years of extra-uterine life, so all of the gender-related differences could not be a 
consequence of some habits of life peculiar to the male. Allen concluded that “it appears 
incontrovertible that there exists a sex-linked inferiority of the male; that mere maleness influences 
unfavorably the resistance of the organism to disease during all ages.” 
The prevalence of illnesses and mortality rates presented by Allen may not be valid any 
more, but a few of his conclusions may well be: even today, most life-threatening diseases affect 
males at an earlier age than females. For example, the age-adjusted incidence rate of most 
cancers, breast and gynaecological cancers excluded, is much higher for males than for females 
(Cook et al. 2009). Likewise, coronary heart disease is markedly more common in men than in 
women. Differences in known risk factors, particularly in cholesterol levels and smoking, 
explain a major part but not all of the gender-based differences (Jousilahti et al. 1999). However, 
when only patients who already have coronary heart disease are studied, male gender seems to 
be associated with better outcomes: After an acute myocardial infarction, younger but not older 
women have higher hospital mortality rates than men (Vaccarino et al. 1999). After coronary 
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artery bypass surgery, younger women seem to be at a higher risk of death than men, but the 
sex difference is less marked in the older age categories (Vaccarino et al. 2002). It has been 
suggested that anatomical differences or differences in thrombotic and fibrinolytic activity may 
account for the different clinical profiles and outcomes of men and women with acute coronary 
syndromes (Hochman et al. 1999). 
Inflammatory autoimmune diseases are more common in females than in males (Sternberg 
2001). Sex hormones modulate the immune system and they are thought to be responsible for 
the more vigorous immune reactions in females, which leads to a better resistance to some 
infections but also a higher incidence of autoimmune diseases (Bouman et al. 2005).  
 
Gender distribution of ICU patients 
In general ICU patient populations, male patients most often make up the majority. In the 
multinational study that created the SAPS II prognostic model, 60% of the 13,152 patients were 
males (Le Gall et al. 1993). ICUs from 35 countries participated in the SAPS 3 study (Metnitz et 
al. 2005). Overall, 61% of the 19,577 patients were males, and the proportion of females ranged 
from 37% to 45% across different regions. 
Fowler et al. (2007) studied adult patients admitted to hospitals in Ontario, Canada, during 
the years 2001-2002. Of the 466,792 patients, 57.0% were women. Obstetric diagnoses accounted 
for 14.0% of all admissions. Of the patients admitted for non-obstetric reasons, 50.1% were 
women and 49.9% men. The age distribution corresponds to the slight predominance of women 
(51.1%) in the general population of Ontario in 2001. However, though males accounted for half 
of the non-obstetric hospital admissions, they accounted for 60.1% of admissions to ICUs. At the 
time of ICU admission, men and women were of comparable age and had similar severity of 
illness scores. However, there were some differences in the distribution of patients to different 
diagnostic categories, with a considerably higher proportion of men than women admitted to 
ICUs after cardiovascular surgery and elective surgery in general. 
 
Outcomes from trauma 
Results from human studies about the association of gender with outcome have been 
discrepant. Berry et al. (2009) studied patients with traumatic brain injury and found worse 
outcomes for males than for females among patients aged over 45 years but not among younger 
patients. Likewise, George et al. (2003) found an increased severity of injury-adjusted risk of 
death for men compared with women in patients that had sustained blunt trauma; the 
difference between genders was most apparent for patients aged over 50 years. In some other 
studies, women had a survival advantage when compared with equally injured men among 
young adult trauma patients (Wohltmann et al. 2001, Mostafa et al. 2002). According to other 
studies, however, females with trauma do not have more favourable outcomes than males when 
patients are appropriately stratified for other variables, including age and severity of injury 
(Gannon et al. 2002, Rappold et al. 2002).  
 
Incidence and outcome of sepsis 
The incidence of severe sepsis is considerably higher for men than for women: Despite an 
approximately equal number of men and women receiving surgical care in a German study, 
more than two thirds of the patients who needed intensive care for severe sepsis were males 
(Wichmann et al. 2000). Men are also more susceptible to septic complications than women 
following trauma (Oberholzer et al. 2000). In Finland, 67% of adult ICU patients with severe 
sepsis are males (Karlsson et al. 2007). The incidence of severe sepsis increases with increasing 
age. An American study found that the age-specific incidence rate of severe sepsis was lower in 
women than in men: after the age of 30 years, women had a rate similar to that of men who 
were five years younger (Angus et al. 2001). 
Whether male gender is also a risk factor for adverse outcomes in those patients who already 
have developed severe sepsis is a controversial issue. Results from studies in surgical patients 
9 
 
 
with sepsis suggest that male gender is associated with increased mortality (Schröder et al. 
1998) or with decreased mortality (Eachempati et al. 1999). Schröder et al. (1998) explained that 
the better outcomes of women might be caused by the observed higher plasma concentrations 
of anti-inflammatory mediators. Adrie et al. (2007) carried out a case-control study comparing 
men and women who were treated for severe sepsis. In accordance with other studies, 63% of 
the patients were men. The authors found a significantly lower in-hospital mortality for women 
of postmenopausal age (over 50 years) than for equally aged men, whereas there was no 
difference between the genders among younger patients. One would expect that gender-based 
differences would be more pronounced among younger patients if they were caused by 
beneficial effects of female sex hormones. Adrie et al. end the discussion about the possible 
mechanisms behind their findings by presenting another plausible answer: differences in 
health-related behaviour over an individual’s life span may eventually lead to outcome 
differences late in life.    
 
Respiratory disorders and general intensive care 
Among patients requiring mechanical ventilation, female gender was associated with increased 
mortality in one study on 357 patients (Kollef et al. 1997), but outcome was not gender-related 
in another study on 580 patients (Epstein and Vuong 1999), nor in a study on 15,757 patients 
that were treated in 361 ICUs in 20 countries (Esteban et al. 2002). In the study by Esteban et al., 
61% of all patients were males. Kaplan et al. (2002) studied 623,718 hospital admissions for 
community-acquired pneumonia of patients aged 65 years or older. Men had higher mortality, 
both unadjusted and after adjustments for confounding factors. Likewise, mortality rates for 
acute respiratory distress syndrome (ARDS) have been higher for men than for women (Moss 
and Mannino 2002). 
Some authors have studied the impact of gender on treatment and outcome in the 
heterogeneous patient populations of mixed medical-surgical ICUs. Romo et al. (2004) 
published a study in which older but not younger women had a higher mortality rate than men. 
However, severity of illness was not assessed with any scoring system in the study, and 
therefore no adjustments for disease severity were made. Moreover, Romo et al. only presented 
ICU mortality rates, not hospital mortality rates. Because of these shortcomings, no firm 
conclusions can be drawn. Valentin et al. (2003) studied a large cohort of patients admitted to 31 
ICUs in Austria and found no statistically significant differences in severity of illness-adjusted 
mortality rates between men and women. However, male patients received an increased level of 
care and had a higher probability of receiving several invasive procedures.  
 
Hormonal factors 
Animal studies have rather consistently shown beneficial effects of female sex hormones after 
trauma or a septic challenge. However, it is not at all clear whether high concentrations of 
estradiol are beneficial or even harmful: May et al. (2008) studied patients who were treated in 
ICUs for more than 48 hours because of trauma or surgical critical illness. Blood estradiol 
concentrations at 48 hours after ICU admission were significantly higher in non-survivors than 
in survivors, with the median value for non-survivors being twice the median for survivors. 
This ratio was of the same magnitude among both men and women. Similar results were found 
by Angstwurm et al. (2005), who studied ICU-treated patients with severe infection. Outcome 
was not influenced by gender. However, blood estradiol concentrations were significantly 
higher in non-survivors than in survivors, regardless of gender. May et al. (2008) present some 
fundamental differences between controlled animal studies and critically ill or injured humans: 
In non-primates, estrogen biosynthesis is limited to the gonads. In humans and other primates, 
estrogen production takes place also in adipocytes, fibroblasts and osteoblasts. This peripheral 
production is stimulated by pro-inflammatory cytokines in the presence of glucocorticoids, i.e. 
stimulated by stress. This means that high estrogen concentrations may be a signal of a strong 
inflammatory response or a biomarker of the severity of illness.  
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In addition, the strong inflammatory response associated with female sex hormones in 
animal studies provided protection against an early death after untreated trauma or untreated 
septic challenge. A forceful inflammatory response may indeed be beneficial at an early stage, 
but exaggerated inflammation may also lead to the multiple organ dysfunction syndrome at a 
later stage. A person with a severe injury or infection would probably benefit from an early 
strong inflammatory response that is subsequently down-regulated when infections are under 
control (Fowler et al. 2009). Thus, an appropriate balance between pro-inflammatory and anti-
inflammatory mediators in the given temporal context is probably more important than the 
concentration of any individual mediator. This explains why there is no easy answer to the 
question whether some extra estradiol would be beneficial or not.  
Prolonged critical illness is accompanied by substantial losses of body protein despite 
feeding (Streat et al. 1987). The catabolism seems to be associated with decreased secretion of 
anterior pituitary hormones and a decline of pulsatility and regularity in their secretion, which 
is apparently caused by impaired hypothalamic stimulation (Van den Berghe et al. 1998). 
Critically ill men seem to be more affected than women by loss of pulsatility of growth hormone 
secretion (Van den Berghe et al. 2000). 
2.2.3 Cellular mosaicism of X-linked genes in females 
There has been increasing interest in recent years in genetic factors unrelated to sex hormones 
as possible mechanisms behind gender differences in the risk of many diseases. Even when 
environmental differences are insignificant, serious morbidity and mortality are greater in 
males (Migeon 2006). The protective effect of female gender, for example against infections, is 
significant in both premenopausal and postmenopausal women, which suggests that factors 
other than sex hormones play an important role (Sperry et al. 2008). The cellular mosaicism of 
females may be one such factor. In each cell, apart from reproductive cells and cells without 
nuclei, females carry two X chromosomes, one maternal and one paternal. Males have a 
maternal X and a paternal Y chromosome, of which the Y carries the genes responsible for 
maleness. The Y chromosome is small and has few functional genes (probably less than 100), 
whereas the X is large and carries more than 1000 genes (Migeon 2006, Spolarics 2007). 
However, though female cells have two Xs, only one is active in each cell: early in development, 
cells randomly choose either the maternal or paternal X to be active; the other X chromosome is 
permanently inactivated (Willard and Carrel 2001). Females are thus cellular mosaics for those 
X-linked genes that are polymorphic. Many of the genes residing on the X chromosome are 
important in the innate immune response (Spolarics 2007). Cellular mosaicism offers protection 
against harmful mutations of X-linked genes and it also seems to be advantageous in the 
immune response to injury and infection (Migeon 2006, Spolarics 2007, Migeon 2008). On the 
other hand, cell mosaicism may lead to a larger number of autoantigens and may be the reason 
for the higher incidence of autoimmune diseases in females (Migeon 2006).  
The situation is made even more complex by the recently discovered fact that approximately 
15% of the genes on the silenced X chromosome escape inactivation, which means that these 
genes are expressed from both the active and inactive chromosome (Carrel and Willard 2005). 
Because of this incomplete X inactivation, many genes are expressed at higher levels in females 
than in males. Another 10% of genes on the silent X are expressed to varying extents, which 
suggests a significant amount of heterogeneity of expression among females. The clinical 
implications of these findings and many other aspects of the function of the X chromosome are 
still poorly understood. As Gunter (2005) put it, “She moves in mysterious ways, and we’ve just been 
given a preview.” 
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2.2.4 Summary  
 According to animal studies, female sex hormones improve immune functions after 
trauma, while male sex hormones cause immunosuppression. This suggests that females 
should tolerate trauma and major blood loss better than males. 
 In humans, high estradiol concentrations are associated with increased mortality in 
critically ill patients. Estradiol may be a marker of the severity of illness and the 
associated strength of the inflammatory response. 
 The age-adjusted incidence rate of most life-threatening diseases is much higher in males 
than in females. This has been largely attributed to behavioural factors, though these do 
not however fully explain the differences. 
 The incidence rate of most autoimmune diseases is higher in females. 
 Males make up the majority of ICU patients fairly consistently across different countries. 
Roughly 60% of the patients are males. 
 Whether gender influences the outcomes of patients who already have a serious illness 
requiring intensive care is a controversial issue. 
 Recent studies suggest that the cellular mosaicism of polymorphic X-linked genes in 
females may contribute to the lower incidence of many serious diseases in women. 
2.3 SEASONAL VARIATIONS IN MORTALITY  
2.3.1 Increased Mortality in Winter 
In the general population, mortality from acute myocardial infarctions and strokes is increased 
in winter, with the seasonal variation increasing with increasing age (Sheth et al. 1999). 
Mortality from respiratory diseases is also higher in winter than in other seasons: Olson et al. 
(2009) used data from a national registry of death records and studied more than 27 million 
deaths in the United States in the period 1992-2003. Among files with a code for pneumonia, the 
mortality rate was 59% higher in winter months (defined as December through February) than 
in summer months (June through August). According to records with a code for chronic 
obstructive pulmonary disease, the mortality rate was 29% higher in winter than in summer. 
The mortality rate of patients with pulmonary fibrosis was 17% higher in winter than in 
summer. There was notably less seasonal variation in mortality rates from lung cancer: the 
mortality rate was 3% higher in winter than in summer.  
Mortality from ischaemic heart disease, cerebrovascular disease and respiratory disease, as 
well as all-cause mortality, is increased in winter both in countries with cold winters and in 
countries with a milder winter climate. Interestingly, the seasonal variations in mortality are 
larger in regions with relatively warm winters compared to cold regions (Laake and Sverre 
1996, The Eurowinter Group 1997). According to the Eurowinter Study, people living in cold 
areas are better prepared to meet the challenge caused by cold weather: for a given cold 
temperature, people living in Finland are much more likely to wear warm clothing, including 
hats, than people living in Italy or Greece. Moreover, thanks to effective heating, people living 
in Finland have higher indoor temperatures in their homes than people living in southern 
Europe (The Eurowinter Group 1997).  
According to Keatinge (2002), roughly half of the excess deaths in winter are caused by 
cardiovascular events. These deaths peak about two days after peak cold. Approximately half of 
the remaining extra winter deaths are caused by respiratory disease. These deaths rise more 
slowly with a peak at 12 days after the peak of a cold spell. In addition to temperature changes, 
influenza epidemics, most commonly occurring during winter months, may be a major cause of 
the excess winter mortality. Reichert et al. (2004) studied the correlations between mortality 
peaks and influenza. Their conclusion was that the winter-season excess mortality is probably 
caused by a single factor, which most likely is influenza. Reichert et al. suggest that weather and 
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other factors may affect the timing and modulate the magnitude of the increase in mortality in 
winter, but the influenza virus is the primary determinant.  
Seasonal variation may affect outcomes from cardiac surgery: Shuhaiber et al. (2008) found 
increased risk–adjusted odds of hospital mortality in patients having operations in winter 
compared with the average across all seasons. 
It is not clear whether there are seasonal variations in patient outcomes in intensive care. In a 
study by Harrison et al. (2004a), the hospital mortality rate of ICU patients in the UK was 32.3% 
in winter (December-February) and 29.3% in non-winter months (March-November). Even after 
adjustments for APACHE II-based probability of death, the winter season was associated with 
increased mortality (adjusted odds ratio 1.10, 95% confidence interval 1.05-1.14, P < 0.001). 
However, Harrison et al. also adjusted for other factors reflecting both the case mix of the 
individual patient and of the patients in surrounding beds. After this, the independent effect of 
winter season was no longer significant. The authors conclude that the excess winter mortality 
observed in ICUs in England, Wales and Northern Ireland can be explained by variation in the 
case mix of admissions.  
2.3.2 The July Phenomenon 
In some countries, staff transition in teaching hospitals takes place in July, when a new 
academic year begins. A large number of inexperienced residents thus start to care for patients 
at the same time. “The July phenomenon”, often mentioned in the literature, refers to concerns 
about the quality of care early in the academic year (Barry and Rosenthal 2003). The study by 
Inaba et al. (2010) found that admission to a large trauma centre at the beginning of the 
academic year was associated with an increased risk of errors resulting in complications. 
However, most other studies addressing this issue, including studies on ICU patients, have not 
found differences in risk-adjusted outcomes of patients treated in July compared with those 
treated in other months (Buchwald et al. 1989, Shulkin 1995, Barry and Rosenthal 2003, 
Finkielman et al. 2004, Bakaeen et al. 2009). Thus, there seems to be little evidence to support the 
existence of a July phenomenon.  
Intensive care patients benefit from being treated by experienced intensivists (Blunt and 
Burchett 2000, Vincent 2000, Baldock et al. 2001). This raises a question of whether the same 
standard of care can be achieved continuously. In a study by Uusaro et al. (2003), admissions to 
Finnish intensive care units during the weekend were associated with a higher mortality than 
weekday admissions. Likewise, Barnett et al. (2002) found that patients admitted to an ICU on 
the weekend have a modestly higher risk of death. However, these findings were not confirmed 
in the study by Wunsch et al. (2004). They found that patients admitted to ICUs on Saturday 
and Sunday had higher crude hospital mortality compared with mid-week admissions, but this 
association was no longer significant after adjustments for differences in case mix. 
In Finland, there are no particular time points of staff transition; young physicians and 
nurses start to work in hospitals throughout the year. However, due to the summer holiday 
season, hospital staff is often less experienced in July than in other months. To what extent this 
might affect the quality of care delivered is not well known. 
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2.3.3 Summary  
 In the general population, mortality from respiratory diseases, ischaemic heart disease 
and strokes is increased in winter. 
 Some authors attribute the excess winter mortality to cold stress, others to influenza 
epidemics. 
 “The July phenomenon” refers to the idea that the quality of medical care might be worse 
in July than in other months. Though the term is often mentioned in the literature, there 
is little evidence to support the existence of such a phenomenon. 
 It is not well known whether there are seasonal variations in patient outcomes in 
intensive care. However, some studies have found an increased mortality of patients 
admitted to ICUs on weekends compared with weekday admissions. 
2.4 INTENSIVE CARE OF THE ELDERLY  
The reader of medical texts concerning the elderly may be confused by the fact that the authors 
of these texts are not unanimous about who should be called “elderly” or “old”. The World 
Health Organization (WHO) uses the term elderly to mean persons aged 60 years or over. 1 
According to WHO statistics, the number of these people in the world is 650 million, but it is 
forecast to triple to 2 billion by 2050. The European Union uses the term elderly for individuals 
aged 65 years or over. 2 This definition is also most commonly used in the medical literature 
(Wood and Ely 2003), but not consistently: some authors have used the word elderly for 
patients aged 70 years or over (Montuclard et al. 2000), some others for patients aged 75 years 
or over (Walther and Jonasson 2004). Some other terms referring to oldness are also used, again 
without consistency. Somme et al. (2003) studied elderly patients and divided them into three 
subgroups: “old” (75-79 years), “very old” (80-84 years) and “the oldest-old” (85 years or over). 
The term oldest old was also used by Shabot and Johnson (1995), but they referred with it to 
patients aged 75 years or over. Boumendil et al. (2005) in turn used the term oldest-old for 
patients aged 80 years or over, while those in the age group 65-79 years were called “young-
old”. The threshold 80 years as a definition of very high age has been used also by many other 
authors in recent years. Patients aged 80 years or over have been called “very elderly” (de Rooij 
et al. 2005, 2006) or “very old” (Bagshaw et al. 2009). 
The lack of agreement in terminology can be seen as a reflection of the fact that for any given 
age there is considerable heterogeneity within populations regarding the presence of chronic 
diseases and functional capacity. The concept of frailty is used to distinguish old people who 
are vulnerable to adverse outcomes because of a poor state of health and loss of physiological 
reserves from those people who are in good shape despite a high chronological age (Boumendil 
et al. 2007). However, there is no unambiguous definition of frailty either.  
2.4.1 Outcomes from Intensive Care  
 
Incidence of severe diseases 
Increasing age increases the susceptibility to serious diseases (Wood and Ely 2003). In an 
American study on the incidence of acute respiratory failure requiring mechanical ventilation, 
the incidence increased almost exponentially with increasing age until the age of 85 years, 
resulting in an 88-fold difference in incidence between the youngest age group studied (5-17 
years) and the oldest group (85 years and over) (Behrendt 2000). Another study determined the 
incidence of severe sepsis (Angus et al. 2001). The incidence was rather high in infants, 
                                                             
1 http://www.who.int/topics/ageing/en/ as accessed on 30th December, 2011 
2 http://ec.europa.eu/health/population_groups/elderly/index_en.htm as accessed on 30th December, 2011 
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decreased quickly in older children, increased slowly through young adulthood and increased 
very steeply with increasing age among those aged over 65 years. Among people aged over 85 
years, the incidence was more than 100-fold that in children. Hospital mortality rates also 
increased with increasing age, being 10% for children and 38.4% for patients aged 85 years or 
over.  
 
Impact of age on short-term outcomes 
When the first severity of illness classification systems for intensive care were developed, 
chronologic age was found to be a risk factor for death from acute illness (Wagner et al. 1983). 
Yet there has been some controversy regarding the significance of age itself as a predictor of 
mortality. According to some authors, old age may not be an independent risk factor, once 
appropriate adjustments for severity of illness or injury are made (Shabot and Johnson 1995, 
Chelluri et al. 1993). Nevertheless, large studies have confirmed that increasing age is associated 
with an increasing risk of in-hospital death (Le Gall et al. 1993, Moreno et al. 2005). However, 
many authors have emphasised that severity of illness, premorbid functional status and co-
morbidities have a much greater impact on the prognosis than age per se, and that old age alone 
should not be used as a reason for withholding intensive care (de Rooij et al. 2005, Boumendil et 
al. 2007). 
Regardless of age, severity of acute illness is the major determinant of short-term prognosis. 
This severity can be quantified with a score based on the level of abnormality of physiological 
parameters, i.e. on the level of divergence from normal physiological homeostasis. The severity 
score can be converted into a probability of in-hospital death (Le Gall et al. 1993, Moreno et al. 
2005). The essential physiological variables that are taken into account in the severity-of-illness 
scores are presented in chapters 2.1 and 2.7 of this thesis. 
Bagshaw et al. (2009) made a large registry-based study on 120,123 adult patients who were 
treated in ICUs in Australia and New Zealand in the years 2000-2005. 15,640 (13%) of the 
patients were aged 80 years or over, and were termed “very old” by the authors. The hospital 
mortality rate for the very old patients was 24.0%, as compared with 16.6% for patients aged 65 
to 79 years, 11.4% for patients aged 40 to 64 years and 7.1% for patients younger than 40 years. 
In a multivariate analysis, increasing age was independently associated with increased hospital 
mortality: for patients aged ≥ 80 years compared with those aged 18-40 years, the adjusted odds 
ratio (OR) for in-hospital death was 5.4, 95% confidence interval (CI) 4.9-5.9. The following 
factors were associated with lower survival: admission from a chronic care facility, co-morbid 
illness, non-surgical admission, greater illness severity, need of mechanical ventilation, and 
prolonged stay in the ICU. 
In a study by Boumendil et al. (2005) from 36 ICUs in France, the hospital mortality rate of 
ICU-treated patients aged 80 years or over was 28%. For patients aged 65-79 years, hospital 
mortality was 22%. According to the authors, there seems to be a selection bias against the 
oldest old patients with severe co-morbidities being admitted to ICUs, as the patients aged 80 
years or over had fewer related diagnoses than the patients aged 65-79 years. 
 
Long-term outcomes of elderly ICU patients 
In an earlier study, Boumendil et al. (2004) aimed to determine factors that affect long-term 
survival of oldest old ICU patients. They prospectively studied 233 patients aged 80 years or 
over who were treated in a medical ICU in France in 1998-1999. These patients accounted for 
16% of all ICU patients during the study period. The mean age ± SD was 86.1 ± 3.8 years (range, 
80-101 years), and the mean SAPS II score was 45.1 ± 18.9. 105 patients (45.5%) were treated 
with invasive mechanical ventilation. The ICU mortality rate was 16.3%. Survival rates from the 
day of ICU admission were 59% at two months, 33% at two years and 29% at 3 years. The 
median and mean survival times after admission were 231 days and 13 months, respectively. A 
multivariate analysis identified the following factors as independent predictors of a poor 
prognosis: the presence of an underlying fatal disease, initial altered level of consciousness, the 
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need of mechanical ventilation, age over 85 years, and diagnosis of shock. If more than two of 
these factors were present, median survival time was only 32 days. The authors also determined 
factors that were predictors of long-term outcome in the subgroup of patients that survived for 
more than two days after hospital discharge. In this group, survival rates were 71% at two 
months and 35% at three years. Severe functional limitation before admission and an 
underlying fatal disease were independent predictors of poor long-term survival. 
Kaarlola et al. (2006) studied the long-term survival and quality of life of 882 elderly patients 
(≥ 65 years of age) who were treated in a medical-surgical ICU in Helsinki, Finland, in 1995-
2000. 1827 younger patients made up the control group. The median APACHE II score was 18 
for the elderly and 14 for the younger patients. The hospital mortality rate was 36.5% for the 
elderly and 27.4% for the younger patients. The cumulative three-year mortality was 57% for 
the elderly and 40% for the younger patients. In the autumn of 2001, the survivors were 
contacted in order to study their health-related quality of life. The response rate among the 
elderly was 87%. The median time from ICU discharge to the response was 3.1 years; the inter-
quartile range (IQR) was 1.9-5.2 years. 30% of the elderly respondents assessed their present 
health state as good, 58% as satisfactory and 12% as poor. The elderly had lower values than the 
younger respondents in indices reflecting physical functioning, but the state of mental health 
was actually better among the elderly than the younger respondents. When interpreting the 
results of Kaarlola et al., one should bear in mind that the number of patients aged 80 years or 
over was rather small (82, i.e. 3.0% of all patients). In addition, none of the elderly patients lived 
in a nursing home before the ICU admission. It seems that critically ill patients with a very poor 
premorbid functional status and most very old patients may have been treated in other ICUs of 
the hospital or may have been refused ICU admission, and thus the study population was 
rather selected. 
In addition to important findings about long-term outcomes, Kaarlola et al. also present some 
interesting data regarding short-term outcomes: all elderly patients with a day one SOFA score 
exceeding 15 died in the ICU. The SOFA (Sequential Organ Failure Assessment) score (Vincent 
et al. 1996) is a system describing the presence and severity of dysfunction or failure of essential 
organ systems. The score is presented in detail in chapter 2.1 of this thesis. 
Roch et al. (2011) studied long-term outcomes of 299 patients aged 80 years or over who were 
treated in a medical ICU in France in 2001-2006. The mean age was 84 ± 4 years and the mean 
SAPS II score was 52 ± 22 (which reflects a high severity of illness). 59% of the patients received 
mechanical ventilation. The hospital, one-year and two-year mortality rates were 55%, 72% and 
79% respectively. A high severity of illness (SAPS II score), an underlying fatal disease and a 
cardiac diagnosis were independent predictors of hospital mortality. Severe acute kidney injury 
seems to be a strong predictor of a poor outcome in this group of patients: renal replacement 
therapy was given to 21 patients, and 19 of these (90%) died in hospital; one patient was still 
alive at two years. The need for mechanical ventilation was also associated with a high 
mortality rate: of the 176 mechanically ventilated patients, 128 (73%) died in hospital. In 2009, 
the health-related quality of life was assessed for the 24 individuals who were still alive at that 
time. The median age of the respondents was 89 years (IQR 87 to 92 years) and the median time 
between hospital discharge and the evaluation was 63 months (IQR 56 to 85 months). The scores 
reflecting physical function were poor. However, the scores reflecting emotional and social 
well-being were rather good and not much different from those of the general population.  
 
Impact of premorbid functional status 
Several studies have shown that a poor functional status of elderly people before hospital 
admission increases the risk of poor outcomes from intensive care regarding both short-term 
and long-term survival (Bo et al. 2003, Boumendil et al. 2004, Chelluri et al. 2004, Bagshaw 
2009). Bo et al. (2003) prospectively studied 659 patients aged 65 years or over who were treated 
in a medical ICU in Italy in 2000-2001. The mean age was 76.6 ± 7.5 years. The mean severity of 
illness seems to have been somewhat lower than in many other studies: the mean APACHE II 
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score was rather low, 13.2 ± 5.3, and only 12.4% of the patients were mechanically ventilated. 
The hospital mortality rate was 14.7%. In a multivariate analysis, the following factors were 
independent predictors of an increased risk of in-hospital death: higher severity of illness 
(APACHE II score), lack of independence in activities of daily living, moderate-to-severe 
cognitive impairment, and low body mass index (BMI). The hospital mortality rate was 8% for 
those patients who had been independent in basic activities of daily living, but 30% for those 
who had been dependent. For patients with no or only slight prior cognitive impairment, 
hospital mortality was 8%, whereas it was 56% for those who had severe cognitive impairment. 
 
Limitations 
When interpreting results of studies that have evaluated the outcomes from intensive care in 
elderly patients, one has to remember that ICU patients represent a highly selected population. 
Patients who are estimated to be too sick to benefit from intensive care are often not even 
referred for ICU admission, and if referred they are often refused admission. Among the 
elderly, severe co-morbidities (e.g. metastatic cancer) and poor preceding functional status 
(dependency on help in daily activities) are strongly associated with an increased likelihood of 
not being admitted to the ICU despite acute critical illness (Garrouste-Orgeas et al. 2005, 2009). 
Patients with severe co-morbidities and functional limitations may thus be underrepresented in 
studies on elderly ICU patients, which in turn may lead to an over-optimistic perception of the 
outcomes of intensive care of the elderly (de Rooij et al. 2005). At the same time one must bear 
in mind that therapeutic activity may be limited because it is more often presumed to be futile 
for severely ill old patients than for younger patients. Some authors have suggested that the fact 
that outcomes for elderly patients are worse than those for younger patients might be partly 
explained by less aggressive treatment (Grant et al. 2000). 
2.4.2 Admission Policies  
 
Principles and practices  
In an editorial, Ely (2003) wrote about the principles of appropriate decision-making when 
considering an ICU admission of an elderly patient. The medical team must estimate the 
benefits that can be achieved with intensive care, considering baseline disease state, quality of 
life and acuity of illness. It is also important to find out about the patient’s preferences 
regarding life support. We should be aware of the limitations of medical care and understand 
that for some severely ill older patients, the right decision is to provide the most peaceful and 
high quality dying process. If however the acute illness is potentially reversible, and if the 
patient can benefit from intensive care and has an individual preference for aggressive care, 
then ICU care is recommended.  
In practice, old age is one of the factors associated with refusal of ICU admission (Joynt et al. 
2001). In a study by Garrouste-Orgeas et al. (2009), senior emergency physicians first 
determined ICU admission criteria for patients aged 80 years or over. After this, a prospective 
study was done in 15 French hospitals in 2004-2006 to find out whether emergency room 
physicians in these hospitals complied with the criteria. There were 1426 patients aged 80 years 
or over who met at least one of the definite ICU admission criteria. However, of these patients, 
the emergency room physicians referred only 31% for ICU admission, and ICU physicians 
admitted 52% of those referred. The authors concluded that physicians were reluctant to 
consider ICU admission for patients aged 80 years or over, despite the presence of criteria 
indicating that ICU admission was certainly or possibly appropriate. It is noteworthy, however, 
that the preselected criteria only included diagnoses or conditions indicating referral, not 
conditions that might be considered as relative or definitive contraindications. The likelihood of 
non-referral was significantly associated with active cancer and with poor functional status in 
addition to increasing age. 
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In another study, Garrouste-Orgeas et al. (2005) found that among those patients who were 
referred for ICU admission the patients for whom admission was refused were older than those 
who were admitted. However, according to a multivariate analysis, age was not an independent 
predictor of refusal. Preceding poor functional status (total dependency) and metastatic cancer 
were strongly associated with an increased likelihood of refusal of admission. 
 
Intercontinental differences 
Admission policies in America are somewhat different from those in Europe. A study by 
Wunsch et al. (2009) compared the use of intensive care during terminal hospitalisations in 
England and the USA. In England, 50.3% of all deaths occurred in hospital, as compared with 
36.6% in the USA. However, only 5.1% of all deaths in England involved intensive care during 
terminal hospitalisation, whereas 17.2% of decedents had received intensive care in the USA. 
This means that half of all hospital deaths in the USA involve intensive care, as compared with 
only one in 10 in England. The difference between the two countries was most notable in the 
oldest age group: of all decedents aged 85 years or over, the proportion receiving intensive care 
during terminal hospitalisation was 1.3% in England as compared with 11.0% in the USA. 
Angus et al. (2004) studied death registry and hospital discharge data from six US states 
(representing 22% of the US population). 22.4% of all deaths in 1999 occurred after ICU 
admission (either in the ICU or during the same hospitalisation). Even 33% of patients who died 
with metastatic cancer were admitted to the ICU during their terminal hospitalisation. 
According to the authors nine of ten Americans polled say that they would like to die at home, 
but in reality more than one in five die using ICU services. 
In a study comparing critical care delivery in Japan and the USA, the proportion of patients 
aged 85 years or older was 4.5 % in the USA and 1.2 % in Japan (Sirio et al. 2002). According to 
the authors, this difference probably reflects cultural differences regarding health care at the 
end of life.   
 
Are we aware of the patients’ preferences? 
The sensibleness of initiating intensive care depends on the outcomes that are likely to be 
achieved and that can be achieved. When a patient’s preferences regarding certain treatments 
are asked for, the probability of different outcomes may not always be presented. A study by 
Fried et al. (2002) showed that anticipated outcomes heavily influence patients’ preferences. The 
authors studied 226 persons aged 60 years or over who had a limited life expectancy due to 
cancer, congestive heart failure or chronic obstructive pulmonary disease. The study 
participants were asked whether they would want to receive a given treatment; the outcome 
without treatment was specified as death. For a low-burden treatment with the restoration of 
current health, 99% of respondents would want the treatment. However, if the anticipated 
outcome was survival but with severe functional impairment, 74% of the participants would not 
choose treatment. If the outcome was survival but with severe cognitive impairment, 89% of the 
participants would not choose treatment. Given the same anticipated outcome, the proportion 
of respondents who wanted treatment also decreased to some extent as the burden of treatment 
(length of hospital stay, amount of testing and invasiveness of interventions) increased. 
Knowing what a patient wants is a prerequisite for being able to honour those wishes. 
Unfortunately, physicians may often not be aware of patients’ preferences. Hamel et al. (1999) 
studied adults who had one of several illnesses associated with an average 6-month mortality 
rate of 50%. The study was done in the USA in the early 1990s. There were 4556 patients who 
stated a preference about care. For 25% of the patients, physicians stated that they were 
unaware of the preferences. Moreover, when the physician had a perception about the patient’s 
wishes, it was incorrect in more than one third of cases; the physician had a correct 
understanding of the patient’s preferences in only 45% of all cases. For 19% of all patients, the 
physician incorrectly believed that the patient wanted care focused on comfort instead of 
prolonging life, and for 12%, the physician mistakenly believed that the patient wanted care 
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focused on prolonging life. Increasing age of the patients increased the probability that 
physicians would erroneously believe that patients did not want life-extending care.   
2.4.3 The Need for Intensive Care Resources in the Future 
In Finland, persons aged 65 years or older constituted 15.0% of the population in 2000 and 
17.5% in 2010. This segment of the population is expected to increase substantially in the near 
future, as the large post-war generations (“the baby boom generation”) reach this elderly age. 
According to the forecast of Statistics Finland, the proportion of individuals aged 65 years or 
over will be 23% in 2020 and 26% in 2030. 3 According to Eurostat, the ageing of the population 
will be a bit slower in most other EU countries than in Finland (partly because of differences in 
the amount of immigration), but the trend is similar everywhere. In the EU as a whole, 
individuals aged 65 years or over made up 17.4% of the population in 2010, and this proportion 
is expected to increase to 24% by 2030. 4  The ageing of the post-war generations, consistently 
low birth rates and increasing life expectancy will change the age distribution dramatically. 
The increasing number of elderly people will increase the demand for intensive care. This 
fact needs prompt attention in order to avoid shortfalls in the supply of specialists and other 
components of care (Angus et al 2000a). Facing the challenge will probably be made even more 
difficult by a shortage of trained personnel, caused partly by the relative smallness of younger 
cohorts (Flaatten 2007). 
In a recent study, Laake et al. (2010) used ICU registry data and population statistics to 
forecast the demand for intensive care services in Norway in the future. In the calculations they 
used three different population growth forecasts published by Statistics Norway (the low 
growth model forecasts population growth to be 11.1% from 2008 to 2025, whereas the high 
growth model forecasts population growth to be 26.4%). The population growth and the change 
in age distribution (a marked increase particularly in the age group 60-79 years) will increase 
the demand for intensive care (ICU bed-days) by roughly one third (between 26% and 37%, 
depending on the population growth forecast model used). 
Increasing age increases the susceptibility to acute respiratory failure requiring mechanical 
ventilation (Behrendt 2000). Needham et al. (2005) aimed to project the impact of the baby boom 
generation’s ageing on the need for mechanical ventilation in Ontario, Canada. They forecast 
that the incidence of mechanical ventilation will increase by 80% from 2000 to 2026. This 
enormous increase is caused partly by the population’s ageing, causing a 31% increase in the 
incidence rate, and by the projected 37% growth of the total population in Ontario. 
Caution is needed when interpreting the results of studies of this kind. They are based on the 
use of intensive care services by different age groups in past years and on population 
projections. Disease incidence rates, indications and contraindications for treatment, as well as 
the treatments themselves are all assumed to remain unchanged. Some changes will most 
probably take place for all of these factors. Nevertheless, it seems obvious that a substantial 
increase in the need for intensive care is to be expected. 
Many studies have shown that old age decreases the likelihood of being admitted to ICUs. 
This may not be the case so much in the future, as many authors have claimed that old age 
alone is not an acceptable reason for withholding intensive care. Patients and their families may 
also request active treatment more often than before. It therefore seems possible that the 
demand for intensive care services might increase even more than can be forecast based on 
population projections.  
On the other hand, there may also be counteracting factors: The costs of medical care are 
often high in the last year of life (Lubitz and Riley 1993). However, there are data showing that 
expenditures in the last year of life decrease with increasing age, particularly for those aged 85 
                                                             
3 http://www.stat.fi/tup/suoluk/suoluk_vaesto_en.html as accessed on 30th December, 2011 
4 http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Population_structure_and_ageing as accessed on 30th 
December, 2011 
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years or over. The main reason for this is that the aggressiveness of medical care in the last year 
of life decreases with increasing age (Levinsky et al. 2001). This finding may suggest that if the 
elderly of tomorrow are healthier and live longer than those of today, possibly a smaller 
proportion of them would need aggressive care in the ICU. 
2.4.4 Summary  
 The term elderly most commonly refers to persons aged 65 years or over. Individuals 
aged 80 years or over are often called very elderly. However, the literature is inconsistent 
regarding the definitions of old age. 
 The incidence rates of many severe disease states, e.g. acute respiratory failure requiring 
mechanical ventilation and severe sepsis, increase with increasing age. 
 Elderly patients have poorer outcomes from intensive care than younger patients. 
 Prognosis depends, however, more on severity of illness and premorbid functional status 
than on age itself. Old age alone is not a contraindication for intensive care.  
 Patients admitted after elective surgery generally have a good prognosis despite old age. 
Elderly patients admitted after emergency surgery tend to have better outcomes than 
equally aged patients admitted for medical reasons.  
 The following factors are associated with a decreased chance of hospital and long-term 
survival: higher severity of acute illness, severe co-morbidities, preceding poor 
functional status (as reflected by dependency on help in activities of daily living or by 
admission from a chronic care facility), failure of multiple organ systems, prolonged ICU 
stay. 
 In patients aged 65 years or over, severe multi-organ failure (SOFA score > 15) predicts a 
very poor prognosis. 
 In patients aged 80 years or over, severe acute kidney injury (need of renal replacement 
therapy) as part of acute critical illness affecting several organ systems is predictive of 
poor outcome. 
 A majority of elderly long-term survivors from ICU-treated critical illness consider their 
quality of life as satisfactory or good. Physical functions are limited, but mental well-
being is not worse than for younger survivors from critical illness.  
 The number of elderly people in society will increase substantially during the next two 
decades. This will most probably cause a marked increase in the need for intensive care. 
2.5 THE RELATIONSHIP BETWEEN HOSPITAL VOLUMES AND PATIENT 
OUTCOMES 
2.5.1 In Surgery, Trauma Care and Cardiology 
There is a convincing amount of evidence showing that hospital volumes have an impact on 
patient outcomes in surgery: the higher the annual number of operations done in a hospital, the 
better the outcomes. In general, the difference in patient outcomes between high-volume and 
low-volume hospitals is largest for complex surgical procedures associated with high risks of 
complications, but a smaller difference seems to be present even for lower-risk procedures. Luft 
et al. (1979) were the first to do a large-scale study on this issue. They made use of a large 
registry and studied data on over 800,000 patients operated on during 1974 and 1975 in 1498 
hospitals in the USA. For 10 of the 12 surgical procedures studied, they found falling death rates 
with an increasing number of operations. 
Later studies have found that increased hospital volumes are associated with improved 
survival following major cardiovascular surgery (Goodney et al. 2003) and surgery for several 
types of cancer (Begg et al. 1998, Sosa et al. 1998, Schrag et al. 2000, Bach et al. 2001).  Birkmeyer 
et al. (2002) studied the mortality associated with six different types of cardiovascular 
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operations and eight types of major cancer resections between 1994 and 1999 in the USA. The 
total number of operations studied was 2.5 million. The magnitude of the effect of hospital 
volume varied considerably according to the type of procedure, with the largest differences 
between high-volume and low-volume hospitals observed for oesophagectomy and pancreatic 
resection. However, the direction of the effect was consistent: for all 14 types of procedure, 
mortality decreased as hospital volume increased. Dudley et al. (2000) made a structured 
review of studies investigating the association between hospital volumes and mortality rates. 
They identified 128 studies addressing 40 different conditions, most of which were surgical 
operations. In 102 of the studies (80%), there was a significant association between high hospital 
volumes and decreased mortality rates. Moreover, there was a trend towards higher mortality 
rates in high-volume hospitals in only 4 studies (3%), and none of these differences were 
statistically significant. 
Birkmeyer et al. (2002) present several plausible explanations for the better outcomes in high-
volume hospitals: these hospitals may have more surgeons who specialise in specific 
procedures, more consistent processes for post-operative care, ICUs with better staffing, and 
better resources for dealing with complications. Surgeon experience indeed has an impact on 
outcomes, and in many cases surgeon volumes (the annual number of certain procedures done 
by a particular surgeon) account for a large part of the differences between high-volume and 
low-volume hospitals (Birkmeyer et al. 2003). In fact, problems associated with “occasional 
surgeons” have been highlighted more than 50 years ago (Hotchkiss 1960).  
In recent years, there has been considerable interest in the USA in concentrating certain high-
risk operations in high-volume hospitals. According to a recent study by Finks et al. (2011), 
median hospital volumes have increased substantially between 1999 and 2008 for several high-
risk operations, particularly complex cancer resections. The rise in volumes has been partly 
caused by an overall increase in the number of operations, but also by a higher concentration of 
procedures in a smaller number of hospitals. Mortality rates have decreased for all the 
procedures studied, and the authors attribute the improved outcomes partly to increased 
hospital volumes and increased regionalisation of care. 
Severely injured trauma patients benefit from being treated in designated trauma centres 
(MacKenzie et al. 2006). However, results from studies investigating the relationship between 
trauma centre volumes and patient outcomes have been inconsistent. Nathens et al. (2001) 
defined a high-volume trauma centre as one treating over 650 severely injured trauma patients 
per year. They studied 1019 patients and found that treatment in high-volume centres was 
associated with improved survival in subgroups at high risk of adverse outcomes. In contrast, 
patients who were very severely injured had worse outcomes at the centres with highest 
volumes in the study by London and Battistella (2003); in the overall population of 98,245 
trauma patients hospital volume was not a significant predictor of death. Some other studies 
have not been able to demonstrate any association between trauma centre volumes and patient 
outcomes (Glance et al. 2004, Demetriades et al. 2005).  
In interventional cardiology, volumes have an impact on outcomes: there is an inverse 
relation between the number of percutaneous coronary interventions performed at a hospital 
and mortality rates after the procedure (Jollis et al. 1994, McGrath et al. 2000, Hannan et al. 
2005).  
2.5.2 In Intensive Care 
A few published studies suggest that high patient volumes are also associated with improved 
outcomes in intensive care. Kahn et al. (2006) studied 20,241 non-surgical patients receiving 
mechanical ventilation in ICUs and found an association between higher hospital volume and 
lower risk-adjusted mortality: when compared with patients treated in hospitals in the lowest 
quartile according to hospital volume (hospitals treating less than 150 patients receiving 
mechanical ventilation per year), patients treated in hospitals in the highest quartile (more than 
400 patients receiving mechanical ventilation per year) had a 34% reduction in the adjusted 
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odds of in-hospital death (adjusted odds ratio 0.66, 95% confidence interval 0.52-0.83). The 
relationship between volume and outcome was independent of the hospital’s academic status. 
In contrast to these findings, two other studies found no clear evidence supporting the existence 
of a relationship between hospital volumes and outcomes of mechanically ventilated patients 
(Needham et al. 2006, Gopal et al. 2011). A French-American study on ICU patients receiving 
renal replacement therapy found no association of patient volumes with outcomes despite very 
large variations in the annual numbers of patients treated (Nguyen et al. 2011).        
Glance et al. (2006) studied a heterogeneous population of 70,757 ICU patients. They 
concluded that “There is evidence that high patient volumes are associated with lower mortality rates in 
high-risk critically ill adults.” However, it is debatable whether the data presented justify such a 
strong conclusion: After adjustments for patient risk factors, there was actually no significant 
association between ICU volume and mortality rates. The authors also divided the patients into 
four strata according to severity of illness (reflected by SAPS II scores), and they did not find a 
volume-outcome association in any of the four groups. A significant association was then found 
between a high “high-risk ICU volume” (defined as the annual volume of patients with a SAPS 
II score over 41 points) and decreased mortality rates. However, this association was not 
significant when patient risk factors were adjusted for; it only reached statistical significance 
when ICU characteristics in addition to patient risk factors were included in the multivariate 
model. 
Durairaj et al. (2005) studied patients admitted to ICUs because of respiratory, neurologic 
and gastrointestinal disorders. They compared hospital mortality rates between tertiles of 
hospital volume (high, medium and low). Among patients treated for respiratory and 
neurologic disorders, there was no difference in risk-adjusted mortality between hospitals of 
different size. Among patients treated for gastrointestinal disorders, severity of illness-adjusted 
risk of death was lower in high-volume hospitals than in low-volume hospitals. In addition, 
when analysing subgroups based on severity of illness, the authors found better outcomes of 
more severely ill patients with respiratory disorders in high-volume hospitals than in low-
volume hospitals.  
In a German study, the hospital mortality rate of ICU-treated patients with severe sepsis was 
not influenced by hospital size (Engel et al. 2007). Peelen et al. (2007) studied the influence of 
ICU volume on hospital mortality in patients treated for severe sepsis in the Netherlands. The 
overall mortality rate was 34.7%. The total number of annual admissions to the ICU had no 
influence on severity of illness-adjusted risk of death. However, there was a significant 
association between the annual number of patients admitted with severe sepsis and a decreased 
hospital mortality rate in this patient group. 
Iapichino et al. (2004) studied data from 89 ICUs in 12 European countries and found that a 
high volume of activity is associated with improved outcomes. However, instead of the number 
of patients, they used “the number of patients per bed per year” as a parameter reflecting 
volume of activity. They calculated that hospital mortality decreased by 3.4% for every five 
extra patients treated per bed per year. Theoretically, one might interpret this result as 
suggesting that increasing occupancy rates would be beneficial. However, the overall ICU 
occupancy rate also had an impact in the study by Iapichino et al., but in the opposite direction: 
a mean occupancy rate of over 80% was a strong predictor of increased mortality. These results 
raise some questions: If an ICU has both a high number of patients per bed per year and a 
lower-than-average mean occupancy rate, then lengths of ICU stay must be relatively short. It 
may not be surprising that short lengths of stay may predict increased survival, as they might 
simply be a reflection of lower severity of illness, irrespective of the severity scores used.  
In conclusion, results from studies addressing the relationship between hospital volumes and 
patient outcomes in intensive care are inconclusive. 
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2.5.3 Summary  
 Among patients undergoing elective high-risk surgery, higher hospital volumes are 
associated with improved outcomes. 
 For many procedures, differences in surgeon volumes explain a large part of the 
differences in patient outcomes between high-volume and low-volume hospitals. 
 A comparable volume-outcome relationship exists in interventional cardiology: the 
higher the amount of percutaneous coronary interventions performed at a hospital, the 
better the outcomes. 
 Severely injured trauma patients benefit from being treated in designated trauma 
centres. 
 Some studies suggest that outcomes from intensive care are better in high-volume 
hospitals than in low-volume hospitals, whereas other studies have not found such a 
relationship. 
2.6 THERAPEUTIC HYPOTHERMIA AFTER CARDIAC ARREST 
2.6.1 Prognosis of Patients with Out-of-Hospital Cardiac Arrest  
The prognosis of patients with out-of-hospital cardiac arrest (OHCA) is poor. According to 
Eisenberg et al. (1990), studies conducted on OHCA patients from 1967 to 1988 in 29 different 
locations reported survival rates to hospital discharge ranging from 2% to 25% for all cardiac 
rhythms and from 3% to 33% for ventricular fibrillation (VF). Kuisma and Määttä (1996) 
reported data on cardiac arrest cases encountered by the Helsinki Emergency Medical Services 
System in 1994. There were 412 patients with confirmed OHCA who were considered for 
resuscitation. In 344 of these, resuscitation was attempted. Of these patients, 16.6% survived to 
hospital discharge. When cardiac arrest was bystander witnessed and of cardiac origin with VF 
as the initial rhythm, survival to hospital discharge was 32.5%. Herlitz et al. (1999) studied 
cardiac arrest data from five European emergency medical systems: Bonn (Germany), Göttingen 
(Germany), Helsinki (Finland), Reykjavik (Iceland) and Stavanger (Norway). These regions 
were chosen for the study because they had shown exceptionally good results in a preliminary 
survey. For patients with a bystander witnessed arrest of cardiac origin, the proportion of 
patients surviving to hospital discharge ranged from 21% to 35%.   
Survival figures are much worse when also rural areas are included: The study by Pell et al. 
(2003) was based on the HeartStart (Scotland) register that collects data prospectively on all 
resuscitation attempts following out-of-hospital cardiopulmonary arrest in Scotland. Of 17,451 
patients with OHCA presumably of cardiac origin, 7% survived to hospital discharge; of 3724 
patients with OHCA presumably caused by non-cardiac aetiologies, only 2% survived to 
hospital discharge.  
Even after initially successful resuscitation, cardiac arrest victims have high mortality rates: 
In Scotland, 75% of the patients admitted to emergency departments died in hospital (Pell et al. 
2003). In Canada, the in-hospital mortality rate of patients admitted to hospital after OHCA 
between 1994 and 2004 was 62%, and outcomes did not change during the study period 
(Redpath et al. 2010). A study from Sweden reported similar results: hospital mortality rates 
remaining slightly above 60% both in the 1980s and in the 1990s with no improvement in 
outcome during the 20-year study period (Herlitz et al. 2003). Studies focusing on patients 
treated in ICUs after resuscitation from cardiac arrest report no better outcomes: hospital 
mortality rates reported from the USA range from 40% to 80%, with a mean mortality rate of 
57% (Carr et al. 2009). In Finland, the prognosis of these patients has been similar and it has not 
changed much over time: in 1986-87 hospital mortality was 61%, whereas in 1999-2001 it was 
59% (Niskanen et al. 2007).  
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2.6.2 Evidence of the Benefits of Therapeutic Hypothermia 
Animal studies have demonstrated that inducing mild hypothermia after resuscitation from 
cardiac arrest limits neurologic damage (Weinrauch et al. 1992, Safar et al. 1996). Two 
randomised controlled human trials published in 2002 showed that mild therapeutic 
hypothermia (TH) improves survival and limits neurologic damage after OHCA (Hypothermia 
after Cardiac Arrest Study Group 2002, Bernard et al. 2002). The inclusion criteria of the larger 
of these trials, the Hypothermia After Cardiac Arrest (HACA) Study, are presented in Table 3.  
 
Table 3. The inclusion criteria of the Hypothermia After Cardiac Arrest (HACA) Study 
• a witnessed cardiac arrest 
• ventricular fibrillation or non-perfusing ventricular tachycardia as the initial cardiac rhythm 
• a presumed cardiac origin of the arrest 
• an age of 18 to 75 years 
• an estimated interval of 5 to 15 minutes from the patient’s collapse to the first attempt at  
   resuscitation by emergency medical personnel 
• an interval of no more than 60 minutes from collapse to restoration of spontaneous  
   circulation 
 
Only patients with severely impaired level of consciousness after resuscitation were eligible: a 
response to verbal commands after the return of spontaneous circulation and before 
randomisation was an exclusion criterion. Nine centres in five European countries participated 
in the study. A total of 3551 patients were assessed for eligibility, of which 275 (7.7%) met the 
inclusion criteria and were enrolled. Patients randomly assigned to the hypothermia group 
were cooled to a target bladder temperature of 32 °C to 34 °C and this temperature was 
maintained for 24 hours from the start of cooling, after which passive rewarming was allowed. 
Patients randomised to the normothermia group were treated with standard care with the goal 
of maintaining normothermia. The primary outcome was a favourable neurologic outcome 
within six months, defined as good recovery or moderate disability (as opposed to severe 
disability, vegetative state or death). The physicians responsible for assessing the neurologic 
outcome were unaware of the treatment assignments. Mortality at six months was 41% (56/137) 
in the hypothermia group and 55% (76/138) in the normothermia group, P = 0.02. One patient in 
each group was lost to follow-up for neurologic status. 55% of patients in the hypothermia 
group (75/136) had a favourable outcome at six months, as compared with 39% of patients in 
the normothermia group (54/137), P = 0.009.  
The study by Bernard et al. (2002) from Australia included 77 patients who were comatose 
after having been resuscitated from OHCA with an initial cardiac rhythm of VF. The patients 
were assigned to treatment with hypothermia (core body temperature reduced to 33 °C and 
maintained at that temperature for 12 hours) or normothermia. 49% of the patients in the 
hypothermia group (21/43) survived and had a good neurological outcome (defined as being 
discharged home or to a rehabilitation facility) as compared with 26% (9/34) of the patients in 
the normothermia group, P = 0.046. 
Some methodological issues in the study by Bernard et al. deserve attention. Firstly, the 
treatment assignment was not randomised in the strict sense of the term. Instead, the day of the 
month determined the treatment assignment: patients were assigned to hypothermia on odd-
numbered days. Secondly, the original plan was to include only 62 patients. After an interim 
analysis of results from 62 eligible patients, a decision was made to continue the study for a 
24 
 
 
further 12 months, after which 77 patients had been enrolled. Despite these shortcomings, the 
study is generally referred to as a high-quality randomised controlled trial and the results from 
this study and the HACA trial together are considered as high-level evidence supporting the 
use of TH. 
2.6.3 Implementation 
In 2003, the International Liaison Committee on Resuscitation (ILCOR) published an advisory 
statement that recommended: 
 Unconscious adult patients with spontaneous circulation after out-of-hospital cardiac 
arrest should be cooled to 32 °C to 34 °C for 12 to 24 hours when the initial rhythm was 
ventricular fibrillation (VF).  
 Such cooling may also be beneficial for other rhythms or in-hospital cardiac arrest (Nolan 
et al. 2003). 
 
TH was promptly implemented in Finnish ICUs: according to a study by Oksanen et al. 
(2007), 19 ICUs of 20 were using TH in the period 2004-2005. Endovascular cooling is the 
preferred method in Finland and the target core temperature has been 32-34 °C, applied mostly 
for 24 h. In the first years of its adoption, TH was used almost exclusively for patients 
resuscitated from VF: for example, in 2004-2005, all ICUs studied reported that they mainly 
used the HACA trial’s inclusion criteria to select patients for TH.  
In many other countries, implementation of TH has been considerably slower. According to a 
survey done in Germany in the autumn of 2005, 24% of ICUs reported having implemented the 
treatment (Wolfrum et al. 2007). Likewise, implementation has been quite slow in the UK: by 
the summer of 2005, 27% of ICUs had implemented TH for patients resuscitated from cardiac 
arrest (Laver et al. 2006). Nevertheless, the situation has changed in the UK in recent years: in 
2009, 86% of ICUs were using TH as part of post-cardiac arrest care; the majority of units had 
started in 2007 or 2008 (Binks et al. 2010). In Italy, only 16% of ICUs used TH for post-
resuscitation care in 2007 (Bianchin et al. 2009).  
2.6.4 Summary  
 Victims of out-of-hospital cardiac arrest have a poor prognosis: at best, survival to 
hospital discharge has been slightly over 30% among patients whose cardiac arrest took 
place in an urban area, was bystander witnessed and of cardiac aetiology.  
 When also rural areas and non-cardiac aetiologies are considered, survival figures are 
much worse, overall survival rates being well below 10%. 
 Even after initially successful resuscitation, hospital mortality is high, roughly 60% for 
ICU-treated patients. 
 Two controlled trials published in 2002 showed that mild therapeutic hypothermia 
improves survival and limits neurologic damage after out-of-hospital cardiac arrest 
when the initial rhythm was ventricular fibrillation. 
 International guidelines recommend that unconscious adult patients with spontaneous 
circulation after out-of-hospital cardiac arrest should be cooled to 32°C – 34°C for 12-24 
hours when the initial rhythm was ventricular fibrillation and that cooling should be 
considered also for patients resuscitated from other initial rhythms or from in-hospital 
cardiac arrest.  
 Implementation of therapeutic hypothermia has been slow in many countries. 
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2.7 BENCHMARKING IN INTENSIVE CARE 
2.7.1 Principles of Comparing Risk-Adjusted Mortality Rates 
ICUs treat patients with life-threatening disorders. Thus, mortality is a robust marker of ICU 
performance (Moreno et al. 2010b). However, crude mortality rates are not very informative if 
no information is presented about the severity of acute illness, co-morbidities and other factors 
that affect prognosis. In the early 1980s, Knaus and co-workers presented a severity of illness 
classification system called APACHE (Acute Physiology And Chronic Health Evaluation) and 
showed how it could be used to enable comparisons of ICU patient populations and outcomes 
(Knaus et al. 1981, 1982a, 1982b). Originally developed in America, the system was soon 
implemented in some other countries. Hospitals from the United States, France, Spain and 
Finland participated in the first multinational study using this severity scoring model (Wagner 
et al. 1984). 
APACHE was soon followed by SAPS (Simplified Acute Physiology Score), which was 
developed in France (Le Gall et al. 1983). The second generation versions of these models, 
APACHE II (Knaus et al. 1985) and SAPS II (Le Gall et al. 1993), have become the most 
commonly used prediction models in the world (Moreno et al. 2010b). These models are used 
for measuring severity of illness and predicting vital status at hospital discharge. They may also 
be useful in clinical trials when patients are stratified into groups according to severity of 
disease (Le Gall 2005).  
The principle is similar in APACHE II and SAPS II: age, severe chronic co-morbidities and 
abnormal values of physiological measurements are given points to produce a score which is 
subsequently converted by a mathematical formula into a predicted probability of death during 
the present hospitalisation. In both scoring systems, the most abnormal value during the first 24 
hours in the ICU is taken into account. The physiological variables used are rather similar, 
though there are some differences. The most important difference between these two models is 
that for risk prediction the APACHE II needs information about the patient’s diagnosis. The 
SAPS II does not need the specific diagnosis; instead the type of admission (scheduled surgical, 
unscheduled surgical, medical) affects the score. The SAPS II scoring is presented in Table 4. 
When the scoring is ready, the next step is to calculate the logit, i.e. the natural logarithm of 
the odds of death, for each patient. For SAPS II, the logit is computed as follows: 
 
logit = -7.7631 + 0.0737(SAPS II score) + 0.9971[ln(SAPS II score + 1)]                   (1) 
 
The logit is then converted into a probability of in-hospital death as follows: 
 
Probability = elogit / (1 + elogit)        (2) 
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Probabilities of death make sense when used as an aggregate measure of risk (Le Gall et al. 
1993). In a group of patients with a probability of death of 0.75, approximately 75% of the 
patients are expected to die, provided that the prediction model fits the population in question. 
However, we cannot know beforehand which of the patients will die and which ones will be 
among the 25% who will survive (Le Gall 2005). Even for an individual patient, the severity 
score (or the associated probability of death) reflects the severity of illness, but the predicted 
probability is never exactly the same as the actual outcome: the probability is always between 0 
and 1 (but never precisely 0 or 1), whereas the outcome for an individual patient is either 
survival or death. For large groups of patients, the commonly used prediction models have 
shown a fairly good ability to discriminate survivors from non-survivors and to predict the 
number of deaths.  
Since these risk-adjustment tools became available, comparing ICU performance with a 
standard, referred to as benchmarking, has become popular. The basic idea is to identify top 
performing units and to explore the factors associated with good performance (Zimmerman et 
al. 2003). The ultimate goal is to learn about and to improve the overall performance. ICUs can 
be compared to each other or to a reference database with respect to many quality indicators, 
one of which is resource consumption. However, given the primary goal of intensive care, an 
essential part of the benchmarking process is the comparison of risk-adjusted mortalities 
(Moreno et al. 2010b). For a group of patients, the sum of individual probabilities equals the 
number of expected deaths. The number of observed deaths divided by the number of expected 
deaths, the O/E ratio, is also called the standardised mortality ratio (SMR). If the SMR for an 
ICU is precisely 1.0, then the number of observed deaths equalled the number of deaths 
expected by the prediction model. It can be interpreted that the unit performed as well as an 
average unit performed in the study that created the prediction model. An SMR below 1 means 
that the observed mortality was lower than predicted by the model; an SMR above 1 indicates 
excess mortality. 
2.7.2 Potential Confounding Factors 
Great caution is needed when SMRs are interpreted. No risk-adjustment model can fully control 
for all differences in patient case mix. Therefore, differences between ICUs in SMRs do not 
necessarily mean true differences in clinical performance. Even if the confounding factors could 
be controlled for, SMRs should still be interpreted with caution. A high or low SMR may 
represent only random variation (Angus 2000b). However, constant differences in SMRs can be 
interpreted as indicators that one should look more deeply into the situation in different units 
to identify the factors associated with the differences (Le Gall 2005). This chapter highlights the 
most important potential confounding factors in comparing risk-adjusted mortalities. 
 
Poor fit of the risk-adjustment model 
The risk-adjustment model may fit well the study population that it was derived from. When 
the model is applied to another patient population, its prognostic performance may be worse 
(Angus et al 1997). The model may systematically overestimate or underestimate the risk of 
death. The adequacy of risk estimation may also differ across different levels of risk: the model 
may e.g. underestimate the mortality of low-risk patients but overestimate the mortality of 
high-risk patients (Livingston et al. 2000). This is called poor calibration or poor fit of the model 
(Angus 2000b). When the calibration of the model is poor, comparing SMRs of units with major 
differences in patient case mix is questionable. If ICUs are ranked according to SMRs, the choice 
of prognostic model may heavily influence the rank of a unit (Bakshi-Raiez et al. 2007). 
Nevertheless, risk-adjustment models that have been specifically developed for intensive care 
are definitely better tools than models derived from administrative data, which are also used in 
ranking ICUs, particularly in the USA (Keegan et al. 2011, Brinkman et al. 2012). 
Over time, treatments change, outcomes tend to improve and prediction models become 
outdated. If benchmarking programmes use old risk-adjustment models, it is probable that the 
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SMRs will be low for most, if not all, ICUs. This has been called grade inflation (Popovich 2002). 
Lower mortality rates than predicted do not mean that there is no need for further 
improvements. 
To solve the problem of worsening prognostic performance of ageing risk-adjustment 
models, new models have been developed. SAPS has been updated to SAPS 3 (Metnitz et al. 
2005, Moreno et al. 2005) and APACHE to APACHE IV (Zimmerman et al. 2006). In the UK, the 
Intensive Care National Audit & Research Centre (ICNARC) has developed its own prediction 
model (Harrison et al. 2007). Other models of importance include the Mortality Probability 
Models (MPMs) (Higgins et al. 2008). However, even if a new model fits perfectly well, its 
prognostic performance will deteriorate as time goes by (Moreno and Afonso 2008).  
An alternative approach to developing a totally new model is to customise an existing model 
to better fit a regional patient population. First-level customisation means that the variables and 
their relative weights are kept unchanged but new coefficients to the logit equation are 
computed. Very good prognostic performance can be achieved with a customised model 
(Metnitz et al. 2009). Whether a benchmarking programme should use an original risk-
adjustment model or a locally customised or even locally created model depends partly on the 
choice of the reference population that the ICUs are to be compared with (Moreno et al. 2005). 
An original model gives the possibility to describe the patient population with a severity score 
that is well-known in the world and to compare the results with those obtained from an 
international reference population. If it is more important to compare ICUs within the 
benchmarking programme with each other, then a well-fitting customised model may be a 
better choice (Angus 2000b, Moreno and Afonso 2008). 
 
The problem of missing data and the impact of sampling rate 
Even if the risk-adjustment model fits well, there are several potential confounders. The more 
abnormal the values of physiological parameters, the higher is the predicted probability. When 
data are missing, the values of the parameters in question are presumed to be within the normal 
range. Thus, patient populations with many incomplete datasets may appear less severely ill 
than they actually are. Consequently, improving data completeness might lead to an increase in 
mean severity of illness and thus a decrease in SMRs. Accuracy of data is also important. 
Ensuring data quality is of fundamental importance (Angus 2000b). 
Changing the frequency of physiological measurements may affect the severity scores. 
Automation of data collection with a clinical information system (CIS) increases the sampling 
rate of physiological data. This increases the probability of obtaining abnormal values and thus 
leads to higher severity-of-illness scores and lower SMRs (Bosman et al. 1998, Suistomaa et al. 
2000). This may cause bias if some ICUs use technology for automatic data collection and others 
do not. It is not known to what extent widespread automation of data collection in a large 
group of ICUs would affect measured outcomes. 
 
Hospital mortality is not a perfect marker of outcome 
Prediction models have traditionally used hospital mortality as a marker of outcome. This is 
based on the idea that a critical illness will have resolved before hospital discharge (Angus et al. 
1997). Moreover, vital status at hospital discharge is seen as an unambiguous endpoint. 
Comparing hospital mortalities may still be problematic. Patients discharged into other 
hospitals or institutional care are calculated as hospital survivors. Some of these patients will 
nevertheless die within the following weeks. Differences in hospital discharge practices can 
therefore cause bias (Kahn et al. 2007a). To avoid this bias, it has been recommended that 
mortality at a fixed time point such as 30-day or 90-day mortality should be substituted for 
hospital mortality (Angus 2000b, Glance and Szalados 2002). If only hospital mortality is 
available, Angus (2000b) has suggested doing analyses with and without patients discharged to 
long-term and rehabilitation facilities. 
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Care of poor quality can affect severity scores 
Severity scores and associated probabilities are thought to reflect severity of illness. However, 
the scoring systems are not able to differentiate between a patient’s poor condition that is 
caused by a severe disease despite adequate treatment and a poor condition that is partly 
caused by care of substandard quality prior to ICU admission or in the beginning of the ICU 
period. 
Despite these shortcomings, benchmarking has become increasingly popular during the last 
two decades. The benchmarking programmes have led to the creation of large databases of ICU 
treatment periods (Harrison et al. 2004b, Zimmerman et al. 2006, Bakhshi-Raiez et al. 2007, 
Moran et al. 2008). There is, however, little evidence that benchmarking results in 
improvements in outcomes (Woodhouse et al. 2009). 
2.7.3 Summary  
 Benchmarking means comparing the performance of an ICU to other ICUs or to a 
standard.  
 The standardised mortality ratio (SMR) is a basic concept in benchmarking. 
 The SMR is calculated by dividing the observed number of deaths by the number of 
deaths expected by the prediction model. 
 The most commonly used prediction models are APACHE II and SAPS II. They quantify 
the severity of illness with a score of points that is converted to a predicted probability of 
in-hospital death. 
 The prognostic performance of a prediction model deteriorates over time. Old models 
tend to overestimate the risk of death. 
 SMRs should be interpreted with caution because they can be affected by several 
confounding factors. Differences in data collection for measuring severity of illness and 
in hospital discharge practices are among the potential confounders. 
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3 Aims of the Study  
The aims of this study were to quantify the changes in the hospital mortality of intensive care 
patients in Finland in recent years, to improve our understanding about the associations 
between less well-known or controversial factors and mortality, to assess the mortality of ICU-
treated cardiac arrest patients, and to evaluate the effect of automation of data collection on 
measuring standardised mortality ratios. The specific questions to be answered were the 
following: 
 
1) Does gender affect the risk of death and length of ICU stay? (Study I) 
 
2) Are there seasonal variations in hospital mortality of Finnish ICU patients? (Study II) 
 
3) To what extent does age influence outcomes and intensity of care? (Study III) 
 
4) Is mortality from severe sepsis influenced by the size of the ICU? (Study IV) 
 
5) Have mortality rates of ICU-treated victims of out-of-hospital cardiac arrest changed in the 
era of therapeutic hypothermia? (Study V) 
 
6) Have outcomes of patients treated in Finnish ICUs changed in recent years? Are possible 
changes in standardised mortality ratios caused by changes in measuring severity of illness or 
do they reflect genuine changes in the quality of intensive care?  (Study VI) 
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4 Methods  
4.1 THE FINNISH INTENSIVE CARE CONSORTIUM 
The Finnish Intensive Care Consortium (later referred to as “the Consortium”) was established 
in 1994 as a co-operation body coordinating a benchmarking programme. The Consortium 
originally comprised nine ICUs. Several new units joined in 1998 and subsequently the 
Consortium grew rapidly: all university hospitals and major non-university hospitals had 
joined by 2002. Since 2007, the referral areas of the ICUs participating in this benchmarking 
programme have encompassed the whole Finnish mainland, which is divided into 20 hospital 
districts. The major hospital in each district is called the central hospital. Five of these are 
university hospitals. In each of the 15 non-university central hospitals, there is one adult ICU, 
which is the sole provider of intensive care to adult patients in that hospital and in many cases 
also treats children older than infants. All these ICUs participate in the Consortium. The major 
ICUs in all university hospitals participate too. However, in university hospitals, there are, in 
addition to the participating units, also some specialised units (cardiothoracic surgical, trauma, 
and neurosurgical ICUs) that are not involved in the Consortium so far. 
The purpose of this co-operation is to measure the quality of care, provide regular reports of 
the performance of participating units and to improve that performance. Detailed data on 
disease characteristics and severity, intensity of care and patient outcomes are prospectively 
collected into the database of the Consortium. To describe and quantify the characteristics and 
severity of disease, APACHE II (Knaus et al. 1985), SAPS II (Le Gall et al. 1993) and SOFA 
(Vincent et al. 1996) scores are documented for each patient. Intensity of care is measured daily 
with Therapeutic Intervention Scoring System (TISS) scores (Keene and Cullen 1983). Vital 
status at ICU and hospital discharge is documented. In recent years, efforts have also been 
made to document six-month-survival and health-related quality of life, but follow-up is not yet 
complete enough to evaluate these. 
Some data, e.g. data on pre-morbidities and vital status at hospital discharge, are entered 
manually into the electronic database. Regarding physiological variables, data collection has 
become highly automated: apart from one single ICU, all units nowadays use clinical 
information systems (CIS) that automatically collect data from patient monitors, ventilators and 
laboratory systems. In addition, special software is used for automatic data transfer from the 
CIS to the central database. Before being submitted to the database, the data are locally 
validated, both by automatic filters searching for technical artefacts and by trained personnel. 
The central database was handled by a company called Intensium until 2010 and has been 
handled by Tieto Healthcare & Welfare since then. Participating ICUs pay a fee for the 
benchmarking services. 
Each ICU receives feedback on its performance compared to other units of similar size and to 
the whole Consortium regarding data completeness, patient case mix, outcomes and resource 
consumption. This feedback is provided on a password-protected internet site. In addition, a 
reporting meeting, providing deeper analyses of the results and an opportunity for discussion, 
is held twice a year.  
Data retrieved from the Consortium’s database were used in this study. 
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4.2 SEVERE SEPSIS 
4.2.1 Definition of Severe Sepsis 
In 1992, a consensus committee of the American College of Chest Physicians (ACCP) and the 
Society of Critical Care Medicine (SCCM) published definitions for sepsis that have become 
widely accepted (Bone et al. 1992). Sepsis is defined as the systemic inflammatory response to 
infection. This definition required a definition of “the systemic inflammatory response 
syndrome” (SIRS). The definitions of SIRS, infection, sepsis and severe sepsis are presented in 
Table 5. 
 
Table 5. Definitions of the systemic inflammatory response syndrome (SIRS), infection, sepsis and 
severe sepsis, according to the ACCP/SCCM consensus conference committee criteria 
 
Term Definition 
SIRS Systemic inflammatory response, which is manifested by the presence of two or 
more of the following conditions: 
1) Temperature > 38 °C or < 36 °C 
2) Heart rate > 90 /min 
3) Respiratory rate > 20 /min or PaCO2 < 32 mmHg (4.3 kPa) 
4) White blood cell count > 12 x 109/l or < 4 x 109/l or > 10% of immature forms 
Infection An inflammatory response to the presence of micro-organisms or the invasion of 
normally sterile tissue by those organisms 
Sepsis SIRS caused by infection 
Severe sepsis Sepsis associated with organ dysfunction, hypoperfusion or hypotension. 
Hypoperfusion and perfusion abnormalities may include, but are not limited to, 
lactic acidosis, oliguria, or an acute alteration in mental status. 
Sepsis-induced 
hypotension 
Systolic blood pressure < 90 mmHg or a reduction of ≥ 40 mmHg from baseline 
in the absence of other causes of hypotension 
Septic shock Sepsis-induced hypotension despite adequate fluid resuscitation along with the 
presence of perfusion abnormalities. Patients who are receiving inotropic or 
vasopressor agents may not be hypotensive at the time that perfusion 
abnormalities are measured. 
 
SIRS can be caused by a large number of clinical conditions. Besides infectious states that 
may produce SIRS, non-infectious causes include, among others, pancreatitis, ischaemia, 
multiple trauma and tissue injury (Bone et al. 1992).  
In 2001, the definitions were re-evaluated by experts representing several international 
societies. The consensus conference concluded that although the diagnostic criteria for SIRS are 
overly sensitive and non-specific, SIRS remains a useful concept, and the current concepts of 
sepsis, severe sepsis and septic shock also remain useful (Levy et al. 2003). This meant that the 
basic definitions were left unchanged. 
The ACCP/SCCM criteria did not include a precise definition of “organ dysfunction”, and 
varying criteria have been used in different studies. The SOFA score (Vincent et al. 1996) is 
commonly used to describe and quantify the presence and severity of organ dysfunction. The 
scoring system is presented in chapter 2.1 of this thesis. Some authors have defined a SOFA 
score for an organ system higher than 0 as organ dysfunction (Brun-Buisson et al. 2004) and a 
score higher than 2 as organ failure (Brun-Buisson et al. 2004, Vincent et al. 2006). This 
categorisation was also used in the Finnsepsis study (Karlsson et al. 2007, Karlsson 2009).        
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4.2.2 The Finnsepsis Study 
The purpose of the Finnsepsis study was to determine the incidence, treatment and outcome of 
severe sepsis in the adult Finnish population (Karlsson et al. 2007). Severe sepsis was defined 
according to the ACCP/SCCM criteria (Bone et al. 1992) as consisting of a systemic 
inflammatory response, suspected or confirmed infection and acute organ dysfunction. 24 ICUs 
from 21 hospitals participated in this prospective cohort study. The inhabitants in the referral 
areas of the participating units accounted for 91% of the total Finnish population. All 4,500 
consecutive ICU admission episodes during a 4-month period (1 November 2004 - 28 February 
2005) were screened for severe sepsis. The criteria for severe sepsis were fulfilled in 470 adult 
patients. Detailed data on diagnoses, disease severity, treatments given and outcomes were 
prospectively collected. The main results of the Finnsepsis study have been published by 
Karlsson et al. (2007, 2009).  
4.3 STUDY PATIENTS  
For studies I-III and V-VI, data were retrieved from the database of the Finnish Intensive Care 
Consortium. To be able to assess hospital mortality correctly, we only included patients 
admitted for the first time during the hospitalisation in question. However, when lengths of 
ICU stay, intensity of treatment and ICU mortality rates were assessed in study III, 
readmissions were also included. The study periods and patient numbers in studies I-III and V-
VI are presented in Table 6. 
 
Table 6. The main questions, study periods and patient numbers in studies I-III and V-VI  
 
 
Study I Study II Study III Study V Study VI 
Main study 
question 
 
Impact of 
gender on 
outcomes 
Seasonal 
variation in 
outcomes 
Intensive care 
of the elderly 
 
Mortality after re-
suscitation from 
cardiac arrest 
Change in 
outcomes in 
recent years 
Study period 1999-2001 1998-2001 1998-2004 2000-2008 2001-2008 
Number of 
patients 24,341 31,040 79,361 3958 85,547 
 
In study V, patients for whom cardiac arrest was registered as the primary reason for ICU 
admission and who were admitted from the hospital’s emergency department made up the 
study population. Study VI was designed to determine the changes in severity of illness-
adjusted hospital mortality in recent years and to evaluate the possible contribution of 
automated data collection to changes in measured outcomes. The proportion of cardiac surgical 
patients was not constant over the years, which was considered a potential confounding factor. 
Therefore cardiac surgical patients were excluded. A flow chart describing the selection of 
patients to study VI is presented in Figure 1.  
Study IV was different from the other studies as it was not based solely on the Consortium’s 
database. Study IV was a retrospective analysis of data collected for the Finnsepsis study. Some 
of the data were collected as part of the routine datasets collected for the Consortium’s 
database; some data were specifically collected for the purpose of the study. Of the 470 adult 
patients with severe sepsis in the study, 18 patients were transferred to the ICU of another 
hospital during the intensive care period. These patients were excluded from study IV, leaving 
a study population of 452 patients with ICU-treated severe sepsis. 
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Figure 1. Flow chart describing selection of patients to the study population in study VI 
 
The protocols of studies I-III and V-VI were approved by the Ethics Committee of Kuopio 
University Hospital and by the board of the Finnish Intensive Care Consortium. The protocol of 
the Finnsepsis study was approved by the ethics committees in each participating hospital. 
4.4 MEASURING SEVERITY OF ILLNESS AND INTENSITY OF CARE  
In studies I-II, severity of illness was quantified with APACHE II scores (Knaus et al. 1985). In 
studies III-VI, SAPS II scores (Le Gall et al. 1993; scoring system presented in chapter 2.7 of this 
thesis) were used to measure severity of illness. The Glasgow Coma Score, GCS (Teasdale and 
Jennett 1974, 1976, Teasdale et al. 1979), is a component of both the APACHE II and SAPS II 
scores, but it was also used as such to describe level of consciousness in study V. In addition, 
SOFA scores (Vincent et al. 1996; scoring system presented in chapter 2.1 of this thesis) were 
used in study VI.   
Intensity of care was measured with Therapeutic Intervention Scoring System (TISS-76) 
scores (Keene and Cullen 1983) in all studies. To measure the mean intensity of care, the mean 
daily TISS score was computed for each patient. TISS scores were first calculated once for each 
calendar day in the ICU. The mean score was then gained by dividing the total sum of the TISS 
scores with the number of TISS determinations. For a patient staying a 24-hour period from 
noon until noon in the ICU, TISS scores were calculated twice, once for each calendar day, and 
the mean daily TISS score was the sum of those two calculations divided by two. 
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Length of ICU stay was used as a surrogate for resource consumption. In study III the 
product of the length of stay and the mean daily TISS score was also used to depict resource 
use, and in study V the total TISS scores per patient were used for this purpose.  
4.5 DATA PROCESSING AND STATISTICAL METHODS 
For categorical variables, data are presented as absolute numbers and percentages. For 
continuous variables, data are presented as means ± standard deviations (SD) or as medians 
with inter-quartile ranges. To test statistical significance, the χ2 test was used for categorical 
variables. The means and distributions of continuous variables were compared with the t test 
and the analysis of variance. The distribution of the length of ICU stay was highly skewed. 
Therefore lengths of stay were compared with the Mann-Whitney U test and with the Kruskal-
Wallis test. 
Multivariate logistic regression analysis, adjusting for severity of illness, was used to assess 
the independent association of the variable studied with hospital mortality. These variables of 
interest were gender in study I, seasons in study II, age in study III, hospital and ICU size in 
study IV, eras before and after the implementation of therapeutic hypothermia for post-cardiac 
arrest care in study V, and changes over time in study VI. In addition, the following methods 
were used: 
In study I, the study population was split into subgroups based on type of admission, 
diagnostic categories, age, and severity of illness (with the median of the APACHE II score, 16, 
as the division line). The logistic regression analysis, assessing the independent association of 
gender with mortality, was repeated in each subgroup. To compare lengths of ICU stay and the 
intensity of care of men and women, we used the analysis of covariance to calculate severity of 
illness-adjusted mean lengths of ICU stay and mean daily TISS scores.  
In study II, we divided the year into four seasons, defining “winter” as the period lasting 
from December to February, “spring” from March to May, “summer” from June to August, and 
“autumn” from September to November. We defined the month of ICU treatment as the month 
during which the patient was discharged from the ICU. The choice of the discharge date instead 
of the admission date was based on the goal to find a possible association between the main 
holiday season and hospital mortality. In Finland, the main holiday season lasts from 
Midsummer in late June to the end of July. Thus, most patients discharged in July spend their 
whole stay in the ICU during the holiday season. Subgroups based on main diagnostic 
categories were also analysed separately. 
In study III, we compared the treatment and outcomes in different age groups using the age 
groups suggested in the SAPS II scoring system (0-39, 40-59, 60-69, 70-74, 75-79 years and 80 
years or over). The SAPS II scores without age points were used to reflect the severity of illness. 
Based on data about the age distribution of ICU patients in 2004 and about population 
projections, we also calculated an estimate of how the change in age distribution will affect the 
need for intensive care resources in Finland by the years 2020 and 2030. 
In study IV, the ICUs that participated in the Finnsepsis study were divided into three 
groups based on their size and academic status. ICUs in university hospitals (n = 7) made up 
one group. These were from four of the five university hospitals in Finland. All 15 non-
university central hospitals participated in the study, as did two regional hospitals from the 
Helsinki district. These two hospitals are not officially called central hospitals, but as they 
functioned like central hospitals elsewhere in the country, the two ICUs were classified as non-
university central hospital ICUs. Units in non-university central hospitals were divided into two 
groups: “large central hospital ICUs” (n = 9) and “small central hospital ICUs” (n = 8).  Units 
defined as “small central hospital ICUs” had less than six beds (median 5) and/or a referral 
population of under 120 000 people. “Large central hospital ICUs” had at least six beds (median 
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8) and a referral population of over 120 000 people. The groups were compared to each other 
with regard to patient characteristics and outcomes. Post-operative surgical patients and 
medical patients were also analysed separately. 
In study V, we tested the hypothesis that outcomes of ICU-treated victims of out-of-hospital 
cardiac arrest might have improved in the era of therapeutic hypothermia (TH). This treatment 
was implemented in most Finnish ICUs by 2003. We defined the period 2000-2002 as “the pre-
hypothermia era” and the years 2003-2008 as “the hypothermia era”. To take into account the 
potential confounding effect of new ICUs that joined the Consortium during the study period, 
we adjusted for the impact of individual departments in the logistic regression analyses and 
also repeated the analyses after excluding all the units that had joined during the study period. 
In study VI, we calculated standardised mortality ratios (SMRs) for each year by dividing the 
number of observed in-hospital deaths by the number of deaths expected by the SAPS II 
prognostic model. We also compared the latter half of the study period (2005 to 2008) to the 
earlier years (2001 to 2004). To test the hypothesis that SMR changes were caused by new ICUs 
joining the Consortium, we adjusted for the impact of individual departments in logistic 
regression analyses and for the impact of new departments as a group in another analysis. We 
also repeated the analyses including only those departments that participated in the 
Consortium already at the beginning of the study period. To find out whether SMR changes 
were caused by changes in discharge practices, we repeated the SMR calculations after 
excluding all patients that had been discharged from a hospital to other hospitals or 
institutional care. To investigate whether changes in data completeness were responsible for 
SMR changes, we repeated the calculations using only complete datasets, i.e. patients with no 
missing data on SAPS II physiological parameters. 
To estimate the relative contribution of automated data collection with the use of a clinical 
information system (CIS) and improved data completeness, i.e. documentation-related factors 
(DRF), to the observed change in odds of death between the admission periods, we used a 
technique similar to that used previously by Birkmeyer et al. (2003) to calculate the relative 
contribution of surgeon volume to the observed associations between hospital volume and 
outcome. We first used multivariate logistic regression analysis to calculate the ORTIME, by 
which we mean the adjusted odds ratio (OR) for in-hospital death in the later period, i.e. in 
2005-2008, compared with 2001-2004. The ORTIME is adjusted for severity of illness (SAPS II 
scores) and the impact of individual ICUs but not for differences in DRFs. We then added the 
variables “use of CIS” and “number of missing SAPS II physiological parameters” and again 
calculated the adjusted OR for in-hospital death in 2005-2008 as compared with 2001-2004; this 
adjusted OR is named ORTIME-DRF. The relative contribution of the DRFs (the use of a CIS and 
improved data completeness) to the association between admission period and outcome was 
calculated as  
 
[(1 − ORTIME) − (1 − ORTIME-DRF)] / [1 − ORTIME]                                                     (3) 
  
We also made a new customised model to predict the probability of in-hospital death. Using 
a stepwise backward procedure in a logistic regression analysis and with death in hospital as 
the dependent variable, the following variables were entered into the model: SAPS II score, ln 
(SAPS II score + 1), the SOFA score during the first 24 hours, use of a CIS for documentation, the 
number of missing SAPS II physiological parameters and the diagnostic groups “drug 
intoxication”, “diabetic ketoacidosis” and “admission for postoperative care after elective 
surgery” - each of these three groups as a binary variable. The inclusion of these diagnostic 
groups was based on clinical judgment and previous experience from the Finnish 
benchmarking programme, which suggest that these groups are associated with a better 
prognosis than is predicted by the SAPS II model. Based on this customised model, the logit (i.e. 
natural logarithm of the odds of death) was calculated for each patient. Then the probability of 
in-hospital death was calculated according to equation (2) in chapter 2.7. The calibration of the 
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model was tested using the Hosmer and Lemeshow goodness-of-fit Ĉ test with eight degrees of 
freedom (Lemeshow and Hosmer 1982), and the discrimination using the area under the 
receiver operating characteristic curve, ROC (Hanley and McNeil 1982), with 95% CIs. The SMR 
was then calculated for each calendar year by dividing the number of observed deaths by the 
sum of individual probabilities obtained with the customised model. Adjusted mortality rates 
were then calculated for each calendar year by multiplying each year’s SMR with the overall 
mean hospital mortality rate. 
P-values < 0.05 were considered statistically significant. All P-values are based on two-tailed 
tests of significance. No corrections for multiple comparisons were made. The SPSS software 
(SPSS Inc., Chicago, IL, USA) was used in the statistical analyses.  
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5  Results 
5.1 INFLUENCE OF GENDER 
5.1.1 Association with Mortality 
Of the 24,341 patients in study I, 61.7% were males. Male patients made up the majority in all 
age groups but the oldest one (Figure 2). The mean age was 57.8 ± 17.9 years for males and 60.4 
± 19.9 for females, P < 0.001. 
 
 
Figure 2. Age and gender distribution of the study population in study I  
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Overall, there were no differences between genders in unadjusted mortality rates: ICU 
mortality was 8.9% for men and 8.8% for women, P = 0.68; hospital mortality was 16.3% for men 
and 16.1% for women, P = 0.71. Unadjusted hospital mortality rates in different subgroups are 
presented in Table 7. 
 
Table 7. Unadjusted hospital mortality rates (%) for men and women  
 
 Men Women P 
Overall  16.3 16.1 0.71 
Among medical admissions  21.5 21.1 0.58 
Among postoperative admissions  8.5 8.4 0.91 
   Elective  4.5 4.9 0.54 
   Unscheduled  13.6 11.8 0.082 
In the diagnostic category     
   Respiratory failure 20.1 18.9 0.45 
   Circulatory failure 31.1 30.0 0.41 
   Gastroenterological surgery 16.4 14.5 0.19 
   Vascular surgery 5.1 5.9 0.31 
   Surgery, other 4.7 3.0 0.13 
   Neurology / neurosurgery 20.5 18.9 0.31 
   Trauma 13.3 12.6 0.72 
   Metabolic / Renal 17.4 19.2 0.24 
   Intoxication 3.8 2.8 0.29 
   Miscellaneous 7.6 6.7 0.66 
In the age group (years)     
   0-44  7.7 6.6 0.12 
   45-54  12.4 11.5 0.42 
   55-64 15.5 15.3 0.90 
   65-74 17.7 18.2 0.61 
   75 or older 29.6 23.9 < 0.001 
Among patients with APACHE II  
scores  
   
   < 16 4.2 3.2 0.006 
   ≥ 16  28.4 28.2 0.77 
 
 
When severity of illness and the effect of different diagnostic categories were controlled for, 
there was no statistically significant difference in the risk of in-hospital death between genders. 
However, male gender was independently associated with increased hospital mortality in some 
subgroups, namely postoperative patients, the oldest age group (75 years or older), and patients 
with relatively low APACHE II scores (Table 8).  
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Table 8. The independent association of male gender with hospital mortality. Results from 
multivariate logistic regression analyses with adjustment for severity of illness (as measured with 
APACHE II scores) and the effect of different diagnostic categories, and for severity of illness within 
diagnostic categories. 
 
 Adjusted OR 95% CI P  
Effect of male gender:    
Overall  1.09 1.00-1.18 0.059 
Among medical admissions  1.02 0.92-1.13 0.74 
Among postoperative admissions  1.33 1.12-1.58  0.001 
   Elective  1.32 0.96-1.82  0.087 
   Unscheduled  1.32 1.07-1.64  0.011 
In the diagnostic category     
   Respiratory failure 0.99 0.80-1.22 0.91 
   Circulatory failure 1.00 0.85-1.16 0.96 
   Gastroenterological surgery 1.42 1.12-1.79 0.004 
   Vascular surgery 0.87 0.62-1.23 0.44 
   Surgery, other 1.58 0.84-2.99 0.16 
   Neurology / neurosurgery 1.27 1.02-1.59 0.037 
   Trauma 1.17 0.78-1.76 0.45 
   Metabolic / Renal 1.01 0.80-1.28 0.92 
   Intoxication 0.84 0.45-1.56 0.57 
   Miscellaneous 1.42 0.66-3.05 0.36 
In the age group (years)     
   0-44  1.00 0.77-1.31 0.98 
   45-54  1.01 0.78-1.31 0.96 
   55-64 1.12 0.90-1.40 0.30 
   65-74 1.02 0.87-1.20 0.78 
   75 or older 1.39 1.20-1.61 < 0.001 
Among patients with APACHE II  
scores  
   
   < 16 1.54 1.25-1.89 < 0.001 
   ≥ 16  1.01 0.92-1.11 0.88 
 
5.1.2 Effect on Lengths of Stay and Intensity of Care 
The unadjusted mean length of ICU stay was 3.2 ± 5.9 days for men and 2.6 ± 4.4 days for 
women, P < 0.001. ICU stay was prolonged for more than 7 days for 10.6% of male patients, but 
only for 7.8% of female patients (P < 0.001). Table 9 shows the mean lengths of ICU stay of men 
and women in each diagnostic category after adjustment for severity of illness. Male patients 
were treated longer than female patients in the overall study population and in most categories. 
Overall, male patients accounted for 66.0% of the total number of days spent in intensive care. 
In the overall study population, unadjusted mean daily TISS scores were 23.8 ± 10.5 for men 
and 22.5 ± 10.3 for women (P < 0.001). However, there were some differences between genders 
in the distribution of patients to various diagnostic categories. The largest difference was in the 
proportion of patients belonging to the category “vascular surgery”, which comprised 18.2% of 
male patients but only 12.3% of female patients. Patients in this diagnostic category had the 
highest TISS scores, and the uneven distribution of patients to this category explains most of the 
difference in intensity of care that was observed in the overall population. After adjustments for 
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the effects of different diagnostic categories and severity of illness, the mean daily TISS score 
was only slightly higher for men than for women (22.6 vs. 22.0, P < 0.001). Within most 
diagnostic categories, differences between the genders in intensity of care were insignificant 
(Table 9).  
 
Table 9. Adjusted lengths of ICU stay and mean daily TISS scores of men and women in different 
diagnostic categories. Analysis of covariance was used to adjust for severity of illness (as measured 
with APACHE II scores) and the effect of different diagnostic categories, and for severity of illness 
within diagnostic categories. Data are presented as adjusted means (95% confidence interval of 
mean). 
 
Adjusted length of ICU stay, days Men Women P  
Overall  3.2 (3.1-3.3) 2.6 (2.5-2.7) < 0.001 
In the diagnostic category     
   Respiratory failure 4.6 (4.3-4.9) 3.9 (3.5-4.2) 0.002 
   Circulatory failure 3.3 (3.1-3.5) 3.0 (2.8-3.3) 0.07 
   Gastroenterological surgery 3.8 (3.5-4.1) 2.6 (2.3-2.9) < 0.001 
   Vascular surgery 2.3 (2.1-2.4) 2.1 (1.9-2.4) 0.39 
   Surgery, other 1.9 (1.7-2.1) 1.6 (1.4-1.8) 0.07 
   Neurology / neurosurgery 3.1 (2.9-3.3) 2.3 (2.1-2.6) < 0.001 
   Trauma 4.3 (3.9-4.7) 3.4 (2.7-4.1) 0.03 
   Metabolic / Renal 3.7 (3.4-4.0) 2.7 (2.3-3.2) < 0.001 
   Intoxication 1.3 (1.2-1.4) 1.3 (1.2-1.4) 0.96 
   Miscellaneous 3.1 (2.4-3.7) 1.8 (0.9-2.6) 0.01 
    
Adjusted mean TISS score / day Men Women P  
Overall  22.6 (22.4-22.7) 22.0 (21.8-22.1) < 0.001 
In the diagnostic category     
   Respiratory failure 22.3 (21.9-22.7) 21.6 (21.1-22.0) 0.02 
   Circulatory failure 22.6 (22.3-22.9) 22.4 (22.0-22.8) 0.44 
   Gastroenterological surgery 24.5 (24.2-24.8) 23.6 (23.2-24.0) 0.001 
   Vascular surgery 33.8 (33.4-34.1) 32.3 (31.8-32.8) < 0.001 
   Surgery, other 20.2 (19.8-20.7) 19.8 (19.3-20.4) 0.28 
   Neurology / neurosurgery 21.2 (20.9-21.6) 20.8 (20.4-21.2) 0.14 
   Trauma 23.3 (22.8-23.8) 22.8 (22.0-23.6) 0.28 
   Metabolic / Renal 21.4 (21.0-21.8) 21.1 (20.6-21.6) 0.32 
   Intoxication 13.8 (13.4-14.2) 13.6 (13.2-14.0) 0.47 
   Miscellaneous 18.1 (17.2-18.9) 17.3 (16.2-18.3) 0.25 
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5.2 SEASONAL VARIATIONS IN MORTALITY 
5.2.1 Excess Mortality in Winter 
There were no major differences in total patient numbers between different seasons. 24.7% of all 
patients in study II were treated in the winter season (December to February). Distribution of 
patients to different diagnostic categories was somewhat different in winter months than in 
non-winter months. The most important difference was that patients in the category 
“respiratory failure” made up 13.6% of the population in winter but only 11.6% in the non-
winter period, P < 0.001. Patients treated in winter were slightly older than those treated in 
other seasons. The proportion of patients aged 75 years or over was 22.8% in winter and 20.9% 
in non-winter, P < 0.001. 
The mean APACHE II score was 16.9 ± 8.9 in winter and 16.9 ± 8.9 in non-winter, P = 0.72. 
Despite comparable severity of illness, hospital mortality was higher in winter than in non-
winter, 17.9% vs. 16.4%, P = 0.003. When the effects of age, severity of illness, 10 major 
diagnostic categories and intensity of care (mean daily TISS scores) were adjusted for, winter 
compared with non-winter was independently associated with increased hospital mortality 
(adjusted OR 1.13, 95% CI 1.04-1.22, P = 0.005). When patients treated during the summer 
months (June to August) were left out from the analysis, the independent impact of the winter 
season on the risk of death was even stronger (adjusted OR 1.17, 95% CI 1.07-1.28, P = 0.001.) 
When the diagnostic categories were analysed separately, the unadjusted hospital mortality 
rate tended to be higher in winter than in non-winter in each of the categories, but the 
difference was not statistically significant in any of them. For the category “respiratory failure”, 
hospital mortality was 22.3% in winter and 19.9% in non-winter, P = 0.10. The effect of the 
winter season remained non-significant in each category also after adjustments for age, severity 
of illness and intensity of care were made using logistic regression analysis. 
As the proportion of patients admitted for respiratory failure was greater in winter, there 
were proportionately more patients who died because of respiratory failure in winter than in 
non-winter: in winter, 233 patients (3.0% of all ICU patients) died after being admitted to the 
ICU for respiratory failure, as compared with 541 patients (2.3%) in non-winter, P < 0.001. 
Compared with the average number of deaths in other seasons, this means 53 extra deaths from 
respiratory failure in winter. The age-adjusted odds ratio for being admitted to the ICU for an 
ultimately fatal respiratory failure in winter rather than in non-winter was 1.30 (95% confidence 
interval 1.11-1.51, P = 0.001). 
5.2.2 Impact of the Holiday Season in July 
The crude hospital mortality rate was at its highest in July (18.8%). However, severity of illness 
was also at its highest in July (mean APACHE II score 17.7). The mean APACHE II scores and 
crude hospital mortality rates for each calendar month are shown in Figure 3. When severity of 
illness and the impact of different diagnostic categories were adjusted for, the risk of death in 
July was not higher than the risk of death during other months (adjusted OR 1.02, 95% CI 0.90-
1.16, P = 0.79). The analysis was also repeated after the patients treated during the other 
summer months (June and August) and the winter months (December to February) had been 
excluded, which means that the severity of illness-adjusted risk of death in July was compared 
to the risk in spring and autumn. For July, the adjusted OR for death was 1.08, 95% CI 0.94-1.23, 
P = 0.27.  
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Figure 3. Mean APACHE II scores and hospital mortality rates in different months 
 
Regarding the reason for the need of intensive care, there were differences between July and 
the other months: 13.8% of the patients treated in July as compared with 18.7% of patients 
treated in other months were admitted to the ICU after elective surgery. Among these patients, 
the mean APACHE II score was relatively low, 14.0. This does explain the higher severity of 
illness in July to some extent, but not fully: among the emergency admissions, the mean 
APACHE II score was 18.3 in July and 17.6 in other months, P = 0.004, despite no significant 
differences in the age of the patients. 
5.3 INTENSIVE CARE OF THE ELDERLY 
5.3.1 Impact of Age on Outcomes and Intensity of Care 
The mean age in the study population was 58.7 ± 18.5 years; 8.9% of the patients were aged 80 
years or older. 62.1% of all patients were males.  
The main results of study III are summarised in Table 10. Medical conditions were the most 
common reasons for admission in the youngest age groups, while almost half of the patients 
aged over 60 years were admitted for surgical conditions. Scheduled surgery as a reason for 
ICU admission was most common in the age groups 60-69 years and 70-74 years. In the oldest 
age group (80 years and older), scheduled surgery was a relatively uncommon cause for 
admission, whereas the proportion of patients admitted because of unscheduled surgery was 
high, 30.8%. Mean severity of illness as measured with the SAPS II score without age points 
increased slightly with increasing age. Overall, the mean SAPS II score, including age points, 
was 33.4 ± 17.6 (median 30, quartiles 21-43). 
The ICU mortality rate increased with increasing age, but the hospital mortality rate 
increased even more: the hospital mortality / ICU mortality-ratio was 1.3 in the age group 0-39 
years, but 2.3 in the age group 80 years and older. Hospital mortality rates for each year of age 
are presented in Figure 4. Mortality rates were highest for old patients admitted for medical 
reasons and for old long-stay patients. Hospital mortality rates for various subgroups are 
presented in Table 11. 
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Figure 4. Age distribution of the study population and hospital mortality rates for each year of life 
 
 
 
 
Table 11. Hospital mortality rates (%) for each age group in subgroups according to gender, type of 
admission and length of ICU stay. For all comparisons between the age groups, P < 0.001. 
 
 Age group (years) 
 Overall  0-39 40-59 60-69 70-74 75-79 ≥ 80 
Males 15.9 6.3 12.6 16.2 19.7 25.4 31.2 
Females 16.0 5.3 12.4 16.1 19.4 22.5 25.9 
Type of admission        
   Medical 21.7 6.9 16.7 25.6 31.5 35.0 37.2 
   Elective surgical 4.0 1.6 2.0 3.3 5.1 6.2 9.5 
   Unscheduled surgical 13.7 3.9 10.4 13.1 15.8 19.0 22.7 
Length of ICU stay        
   < 7 days 14.8 5.5 11.8 14.8 18.0 21.6 26.7 
   > 7 days 29.4 10.7 20.4 32.0 38.9 45.7 51.4 
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In the multivariate logistic regression analysis testing the independent effect of age on 
hospital mortality, the adjusted OR for one additional year of age was 1.035 (95% CI, 1.033-
1.037). Among male patients, the adjusted OR was 1.037 (95% CI, 1.035-1.040); among female 
patients, it was 1.032 (95% CI, 1.029-1.035). However, when only patients aged 65 years or older 
were included in the analysis, the adjusted OR for one additional year of age was 1.053 (95% CI, 
1.045-1.061) for males and 1.035 (95% CI, 1.027-1.044) for females. We also repeated the logistic 
regression analysis using age groups instead of age as a variable. The results are presented in 
Table 12. 
 
Table 12. The independent association of age group with hospital mortality. Results from a logistic 
regression analysis with adjustment for severity of illness (SAPS II scores without age points), 
intensity of care (mean daily TISS scores), gender, year of admission and the impact of individual 
departments. P < 0.001 for each age group. 
 
Age group Adjusted OR 95% CI 
0-39 Reference  
40-59 2.05 1.84-2.29 
60-69 3.17 2.83-3.55 
70-74 4.14 3.68-4.66 
75-79 5.41 4.81-6.10 
≥ 80 7.08 6.26-7.99 
 
The mean intensity of care was at its highest in the age group 70-74 years (Table 10). The 
mean daily TISS scores were only slightly lower in the age group 75-79 years, but notably lower 
for patients aged 80 years or older. Nevertheless, there were patients who were treated with 
aggressive interventions also in the oldest age group: of patients aged 80 years or older, 17.8% 
received a pulmonary artery catheter and 2.3% received haemodialysis treatment as compared 
with 25.5% and 4.6%, respectively, of younger patients. At least two vasoactive drugs were 
simultaneously infused to 23.1% of patients aged 80 years or older but only to 20.6% of younger 
patients, P < 0.001. For patients aged 80 years or over, as compared with younger patients, the 
severity of illness-adjusted odds ratio for receiving several vasoactive drug infusions was 1.08 
(95% CI, 1.01-1.14, P = 0.019). 
Overall, the mean length of ICU stay was 3.1 ± 5.3 days (median 1.3, quartiles 0.8-3.0; Table 
10). The length of ICU stay was at its longest in the age group 75-79 years, while lengths of stay 
were considerably shorter in the oldest age group. In particular, the proportion of very long 
ICU stays was low among the oldest patients: the ICU stay lasted longer than seven days for 
10.3% of patients younger than 80 years, but only for 6.8% of patients aged 80 years or older (P < 
0.001). The decision of whether or not care was restricted was documented in the database for 
68,388 admissions (86.2%). Restrictions for future care were set for 15.1% of patients aged 80 
years or older, but only for 6.7% of younger patients (P < 0.001). 
The total amount of time spent in intensive care during the study period was 242,398 days. 
Figure 5 depicts the proportion of ICU days accounted for by each year of life and the 
proportion of days taken up by patients older than a given age. Patients aged 63 years or older 
accounted for 49.9% of all ICU days. The proportion of ICU days was 33.4% for patients aged 70 
years or older and 7.1% for patients aged 80 years or older.  
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Figure 5. Total number of days spent in an ICU for each year of life and the cumulative percentage 
of ICU days. Each point on the line shows the proportion of ICU days taken up by patients older than 
the corresponding age. 
 
We do not know the exact costs of intensive care for individual patients. Instead, we used 
length of ICU stay and the multiplication of a patient’s mean daily TISS score by the exact 
length of ICU stay to depict resource use. Table 13 presents the amount of resources used in 
each age group per one hospital survivor. The cost of one life saved was highest in the age 
group 75-79 years and remarkably lower in the oldest age group. 
 
Table 13. The amount of resources used per one life saved in different age groups 
 
 Age group (years) 
 Overall 0-39 40-59 60-69 70-74 75-79 ≥80 
Days of ICU care / survivor a 3.6 2.8 3.6 3.8 4.1 4.2 3.4 
TISS x days / survivor b 108.6 73.3 108.2 119.5 128.6 130.5 99.4 
a In each age group, the sum of time spent in ICU care was divided by the number of hospital survivors. 
b For each patient, the mean daily TISS score was multiplied by the length of stay to get a score taking into 
account both the length of stay and the intensity of care. In each age group, the sum of this score was divided 
by the number of hospital survivors. 
 
There were large differences between departments in the treatment of the oldest patients. 
Among those departments that were the sole intensive care units in the hospital, the proportion 
of patients aged 80 years or older ranged from 3% to 18% (mean 9%). The hospital mortality rate 
of these patients ranged from 16% to 40% (mean 28%).  
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5.3.2 Influence of the Ageing Population on the Need for Intensive Care 
In 2004, the age group 65 years or older (15.9% of the Finnish population at that time) accounted 
for 43.0% of all days in intensive care. This age group is predicted to make up 26% of the 
Finnish population in 2030. Based on data about the age distribution of ICU patients and about 
population projections, and assuming no changes in the age-adjusted need for intensive care, 
we calculated that the need for intensive care resources (ICU bed-days) in Finland will increase 
19% by the year 2020 and 25% by the year 2030, compared to the number of bed-days in 2004.  
5.4 INFLUENCE OF HOSPITAL AND ICU SIZE ON OUTCOMES OF PATIENTS 
WITH SEVERE SEPSIS 
Patient characteristics and outcome data from study IV are presented in Table 14. There were 
some minor differences between the ICU groups in the case mix. The proportion of 
postoperative admissions was smaller in large central hospital ICUs than in the other two 
groups. There were no differences in the total SAPS II scores. Differences between groups 
regarding the site of infection were small and statistically non-significant. Therapeutic intensity, 
as measured with the mean TISS score per day, was higher in university hospitals than in non-
university central hospitals. Overall, the ICU, hospital and 1-year mortality rates were 15.9%, 
29.2%, and 40.7%, respectively. The hospital mortality rate in the group of all central hospital 
ICUs (30.6%) was not significantly different from that in the university hospital ICUs (27.8%), P 
= 0.51.  
The hospital mortality rate was 37.7% for patients treated in small central hospital ICUs and 
27.5% for those treated in larger units (including university and large non-university hospital 
ICUs), P = 0.073; risk ratio (RR) 1.37, 95% confidence interval (CI) 0.985-1.91. In post-operative 
patients, the hospital mortality rate was 42.3% for patients treated in small central hospital ICUs 
and 22.9% for patients treated in large ICUs, P = 0.045; RR 1.85, 95% CI 1.05-3.27. In medical 
patients, there were no differences between ICU groups in hospital mortality (Table 15). 
Similarly there was a significant difference in the long-term outcome among post-operative 
patients, but not among medical patients (Figure 6). 
Logistic regression analysis was used to adjust for severity of illness (SAPS II scores). 
Treatment in small central hospital ICUs as compared with large ICUs was associated with an 
increased risk of in-hospital death, adjusted OR 1.82, 95% CI 1.03-3.22, P = 0.038.  
The median length of ICU stay (LOS) was 7.2 days (quartiles, 3.7-12.6) for patients in small 
central hospital ICUs and 5.6 days (3.0-11.1) in large ICUs, P = 0.08. For hospital survivors, there 
was no difference between the ICU groups in lengths of stay. For non-survivors, the median 
LOS was 10.0 days (4.6-16.5) in small ICUs and 4.9 days (1.9-12.2) in large ICUs, P = 0.032. The 
sum of all days in ICU care divided by the number of hospital survivors was 15.0 for small 
central hospital ICUs and 11.1 for large ICUs. Thus, small ICUs used more resources per one life 
saved when resource consumption is measured by lengths of ICU stay. 
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Table 14. Patient characteristics and outcomes  
 
 Small central 
hospital ICUs 
Large central 
hospital ICUs 
University  
hospital ICUs 
P 
Number of patients, n (%) 77 (17.0) 145 (32.1) 230 (50.9)  
Number of patients per unit, 
median (range) 
10 (3-15) 15 (9-22) 29 (19-53)  
Males, n (%) 48 (62.3) 95 (65.5) 159 (69.1) 0.51 
Postoperative admissions, n (%) 26 (33.8) 35 (24.1) 70 (30.4) 0.01 
Age, years, mean ± SD 62.3 ± 14.7 59.1 ± 16.2 59.1 ± 15.0 0.24 
SAPS II score without age points, 
mean ± SD 
32.7 ± 16.4 37.4 ± 17.0 33.7 ± 14.7 0.04 
SAPS II score, mean ± SD 43.7 ± 17.7 47.3 ±18.7 43.6 ± 15.5 0.10 
Site of infection, n (%)    0.22 
Pulmonary 25 (32.5) 59 (40.7) 97 (42.2)  
Intra-abdominal 32 (41.6) 49 (33.8) 64 (27.8)  
Urinary 5 (6.5) 4 (2.8) 13 (5.7)  
Skin or soft tissue 4 (5.2) 13 (9.0) 27 (11.7)  
Others 4 (5.2) 7 (4.8) 17 (7.4)  
Unknown 7 (9.1) 13 (9.0) 12 (5.2)  
TISS per day, mean ± SD 33.3 ± 6.4 33.7 ± 6.3 39.4 ± 8.0 < 0.001 
Length of ICU stay, days 
   Mean ± SD 
   Median (quartiles) 
 
9.3 ± 8.3 
7.2 (3.7-12.6)  
 
7.8 ± 6.8 
6.0 (3.1-11.3) 
 
8.2 ± 8.9 
5.1 (2.7-11.1) 
 
 
0.17 
ICU mortality, n (%) 16 (20.8) 25 (17.2) 31 (13.5) 0.28 
Hospital mortality, n (%) 29 (37.7) 39 (26.9) 64 (27.8) 0.20 
SMR (95% CI) 1.03 (0.72-1.49) 0.65 (0.47-0.89) 0.81 (0.64-1.04)  
One-year mortality, n (%) 38 (49.4) 55 (37.9) 91 (39.6) 0.23 
SMR, Standardised Mortality Ratio, i.e. the number of observed in-hospital deaths divided by the number of 
deaths expected according to the SAPS II prognostic model 
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Table 15. Hospital mortality rates [percentages (n)] in certain subgroups in small central hospital 
ICUs and in large ICUs. “Large ICUs” include both university hospital ICUs and large non-university 
central hospital ICUs. 
 
 Small central 
hospital ICUs 
Large ICUs P  
All patients 37.7 (29/77) 27.5 (103/375) 0.07 
Postoperative admissions 42.3 (11/26) 22.9 (24/105) 0.045 
Medical admissions 35.3 (18/51) 29.3 (79/270) 0.39 
Age     
  < 65 years 23.1 (9/39) 21.3 (50/235) 0.80 
  ≥ 65 years 52.6 (20/38) 37.9 (53/140) 0.10 
Length of ICU stay    
  < 7 days 29.7 (11/37) 25.3 (58/229) 0.57 
  ≥ 7 days 45.0 (18/40) 30.8 (45/146) 0.09 
  ≥ 14 days 61.5 (8/13) 28.3 (17/60) 0.02 
 
 
  
 
 
Figure 6. Survival curves of surgical post-operative and of medical patients treated in large ICUs 
(including university and large non-university central hospital ICUs) and in small central hospital 
ICUs  
 
 
 
52 
 
 
5.5 MORTALITY OF PATIENTS RESUSCITATED FROM CARDIAC ARREST  
The age distribution of the patients did not change between the two study periods in study V. 
Severity of illness was higher in the latter period. Despite this, hospital mortality decreased 
from 57.9% to 51.1%, P < 0.001 (Table 16). When logistic regression analysis was used to adjust 
for severity of illness (SAPS II score), gender and the impact of individual ICUs, treatment in 
2003-2008 was associated with a significantly reduced risk of in-hospital death (adjusted OR 
0.54, 95% CI 0.45-0.64, P < 0.001). When the year of admission (instead of treatment period) was 
used as an explanatory variable, the severity of illness-adjusted risk of death decreased 
markedly between the years 2002 and 2003. This improvement has persisted, but there was no 
further improvement after 2003 (Table 17).  
The median age of the patients was 66 years. In patients younger than this, hospital mortality 
was 52.1% in 2000-2002 and 45.1% in 2003-2008, P = 0.012. In patients aged 66 years or over, 
hospital mortality was 62.7% in 2000-2002 and 57.3% in 2003-2008, P = 0.036. After adjustment 
for SAPS II scores, gender and the impact of individual ICUs, treatment in 2003-2008 had a 
strong and consistent independent effect on risk of in-hospital death (for patients under 66 
years of age, adjusted OR 0.53, 95% CI 0.41-0.69, P < 0.001; for patients aged 66 years or over, 
adjusted OR 0.55, 95% CI 0.42-0.70, P < 0.001). 
Males made up the majority of patients. For male patients, hospital mortality was 56.1% in 
2000-2002 and 49.3% in 2003-2008, P = 0.003. For female patients, hospital mortality was 61.8% 
in 2000-2002 and 56.4% in 2003-2008, P = 0.12. After adjustment for SAPS II scores and the 
impact of individual ICUs, treatment in the latter period was associated with decreased hospital 
mortality for patients of both genders (for males, adjusted OR 0.55, 95% CI 0.44-0.68, P < 0.001; 
for females, adjusted OR 0.49, 95% CI 0.35-0.70, P < 0.001). 
The Finnish Intensive Care Consortium grew during the study period: altogether six new 
ICUs joined. Outcomes of patients treated in these new units were not better than outcomes of 
patients treated in the Consortium’s older units.  
 
Table16. Characteristics of the study population and figures describing ICU care and outcomes 
 2000-2002 2003-2008 P  
Hospitals in the Consortium 20 21  
Number of ICUs 21 24  
Number of patients 886 3072  
Males, % 68.8 73.8 0.003  
Age  64.4 ± 15.0 63.5 ± 14.7  0.11 
SAPS II score  58.1 ± 17.8 61.6 ± 16.9 < 0.001 
Worst GCS score during first 24 h  3 (3-6) 3 (3-6) 0.94 
Length of ICU stay, days  
  Mean ± SD    
  Median (quartiles) 
 
2.7 ± 3.1 
1.9 (1.0-3.2) 
 
3.2 ± 3.5 
2.3 (1.2-3.9) 
 
< 0.001 b 
< 0.001 c 
   Mean ± SD 2.7 ± 3.1 3.2 ± 3.5 < 0.001 
   Median (quartiles) 1.9 (1.0-3.2) 2.3 (1.2-3.9) < 0.001 
Mean daily TISS score 
  Mean ± SD    
  Median (quartiles) 
 
27.4 ± 8.4 
26.3 (22.0-31.2) 
 
33.0 ± 8.0 
32.5 (27.5-38.2) 
 
< 0.001 b 
< 0.001 c 
   Mean ± SD 27.4 ± 8.4 33.0 ± 8.0 < 0.001 
   Median (quartiles) 26.3 (22.0-31.2) 32.5 (27.5-38.2) < 0.001 
Therapeutic hypothermia, % 1.8 36.2 < 0.001 
ICU mortality, % 25.4 21.6 < 0.001 
Hospital mortality, % 57.9 51.1 < 0.001 
Adjusted OR (95% CI) Reference 0.54 (0.45-0.64) < 0.001a 
Data on continuous variables presented as means ± standard deviation or medians (quartiles). aMultivariate 
logistic regression analysis (the impact of SAPS II scores, gender and  individual ICUs was adjusted for). 
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Table 17. Results of a logistic regression analysis testing the independent effect of SAPS II 
scores, gender and admission year on risk of in-hospital death. The impact of individual ICUs was 
adjusted for. Patients treated in ICUs that joined the benchmarking programme during the study 
period were excluded.  
 Adjusted OR 95% CI P 
SAPS II score (for each additional point) 
point point) 
1.08 1.07-1.08 < 0.001 
Male gender 0.72 0.59-0.87 0.001 
Admission year 
   2000 
 
Reference 
  
   2000 Reference   
   2001 1.03 0.69-1.52 0.90 
   2002 0.95 0.65-1.39 0.77 
   2003 0.53 0.37-0.77 0.001 
   2004 0.54 0.37-0.78 0.001 
   2005 0.62 0.43-0.89 0.010 
   2006 0.58 0.40-0.84 0.004 
   2007 0.54 0.38-0.79 0.001 
   2008 0.46  0.32-0.67 < 0.001 
 
For all patients treated with therapeutic hypothermia (TH) in 2003-2008, hospital mortality 
was 36.8%; for patients treated without TH, it was 58.9% (P < 0.001). The patients treated with 
TH were younger and less severely ill than those not treated with TH (mean age 60.1 ± 14.0 vs. 
65.4 ± 14.7, P < 0.001; mean SAPS II scores 59.0 ± 15.7 vs. 63.1 ± 17.4, P < 0.001). 
In 2003, the proportion of patients treated with TH was 21.7%. This proportion steadily 
increased until 2007, when it was 44.0%. In 2008, 43.1% of the patients were treated with TH. 
However, we found no further improvements in survival rates after the year 2003 despite the 
increasing use of TH. Over the years, TH was given to more severely ill patients and 
consequently the mortality of TH-treated patients actually increased: during the years 2003-
2004, the mean SAPS II score of TH-treated patients was 54.8 ± 16.3 and the hospital mortality 
rate was 29.7%; in 2007-2008, the mean SAPS II score was 60.2 ± 14.4 and the hospital mortality 
rate was 39.5%.  
Lengths of ICU stay (LOS) were longer and mean intensity of care was higher in 2003-2008 as 
compared with earlier years (Table 16). The increase in mean LOS was associated with the use 
of TH: for patients treated without TH, mean LOS in 2003-2008 was 2.6 ± 3.2 days, which is 
similar to the mean LOS in 2000-2002. For patients treated with TH in 2003-2008, mean LOS was 
4.3 ± 3.6 days. Intensity of care has increased even among those not treated with TH: in 2003-
2008, the mean daily TISS score of patients not receiving TH was 30.1 ± 7.4, which is higher than 
the score of 27.4 ± 8.4 of patients treated in 2000-2002. For patients treated with TH, the mean 
daily TISS score in 2003-2008 was 38.0 ± 6.3. Overall, the mean total TISS score per patient (the 
sum of daily TISS score calculations) increased from 105 in 2000-2002 to 142 in 2003-2008, 
reflecting a 35% increase in resource use in the treatment of this patient group. 
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5.6 CHANGES IN HOSPITAL MORTALITY OF FINNISH INTENSIVE CARE 
PATIENTS OVER TIME 
5.6.1 Changes in Outcomes  
The crude hospital mortality rate decreased from 18.8% in 2001-2004 to 18.0% in 2005-2008. As 
mean severity of illness increased, risk-adjusted mortality decreased (Table 18, Figure 7). The 
SAPS II-based SMR was 0.74 (95% CI, 0.72-0.75) in 2001-2004 and 0.64 (95% CI, 0.62-0.65) in 
2005-2008. Over the time, outcomes improved in all major admission categories (Table 19). Both 
crude hospital mortality rates and SMRs were lowest in the youngest age groups. In addition, 
outcomes improved most in the youngest age group and least in the oldest group (Table 20). 
The mean intensity of care, as measured with TISS scores, increased over the years. There was 
no change in mean lengths of ICU stay. A very small, yet statistically significant, decrease in 
mean lengths of hospital stay was found (Table 18). 
 
Table 18. Patient characteristics and outcomes 
 
 2001-2004 2005-2008 P  
Number of patients 38,482 47,065  
Number of departments 
  In university hospitals 
  Non-university central hospitals 
23 
8 
15 
24 
8 
16 
 
Males,  % 60.0 61.7 < 0.001 
Type of admission, % 
  Scheduled surgical 
  Emergency surgical      
  Medical 
 
14.9 
21.2 
63.9 
 
12.0 
21.9 
66.1 
< 0.001 
 
 
 
Age (years), mean ± SD 59.3 ± 17.1 58.8 ± 17.2 < 0.001 
SAPS II score, median (IQR) 33 (22-47) 35 (24-50) < 0.001 
SOFA score, median (IQR) 5 (3-8) 6 (3-9) < 0.001 
TISS / day, median (IQR) 24.7 (18.5-31.3) 27.4 (21.0-33.7) < 0.001 
Length of ICU stay, days 
  Median (IQR) 
  Mean ± SD   
 
1.5 (0.8-3.3) 
3.2 ± 5.4 
 
1.6 (0.8-3.6) 
3.2 ± 5.2 
 
< 0.001 
0.51 
Length of hospital stay, days    
  Median (IQR) 9 (5-17) 9 (5-17) < 0.001 
  Mean ± SD   14.4 ± 17.8 14.1 ± 17.4 0.02 
ICU mortality, % (95% CI) 9.9 (9.6-10.2) 8.8 (8.6-9.1) < 0.001 
Hospital mortality, % (95% CI) 18.8 (18.4-19.2) 18.0 (17.6-18.3) 0.002 
SMR (95% CI) 0.74 (0.72-0.75) 0.64 (0.62-0.65)  
Adjusted OR (95% CI) a Reference 0.76 (0.73-0.79) < 0.001 
a Severity of illness (SAPS II score) and the impact of individual ICUs were adjusted for. 
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Figure 7. The number of adult patients treated in ICUs participating in the Finnish Intensive Care 
Consortium and the change in standardised mortality ratio (SMR) during 2001-2008. Bars show the 
annual number of patients, dots and whiskers show the SMRs with 95% confidence intervals. The 
SMR was calculated for each year by dividing the number of observed in-hospital deaths by the 
number of deaths expected by the SAPS II prognostic model. 
 
 
Table 19. Outcomes for different admission types.  Odds ratios (OR) compare the odds of death in 
2005-2008 with 2001-2004 (SAPS II scores and the impact of individual ICUs were adjusted for). 
 
  2001-2004 2005-2008 P  
Admission type     
Scheduled 
surgical 
Hospital mortality, % 
SMR (95% CI) 
Adjusted OR (95% CI) 
4.8 
0.62 (0.54-0.69) 
Reference 
3.4 
0.42 (0.37-0.49) 
0.65 (0.52-0.81) 
< 0.001 
 
< 0.001 
Emergency 
surgical 
Hospital mortality, % 
SMR (95% CI) 
Adjusted OR 
15.3 
0.62 (0.58-0.66) 
Reference 
14.8 
0.55 (0.52-0.58) 
0.78 (0.70-0.86) 
0.36 
 
< 0.001 
Medical 
Hospital mortality, % 
SMR (95% CI) 
Adjusted OR 
23.0 
0.77 (0.75-0.79) 
Reference 
21.7 
0.67 (0.65-0.69) 
0.77 (0.73-0.81) 
< 0.001 
 
< 0.001 
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Table 20. Outcomes in different age groups. Odds ratios (OR) compare the odds of death in 2005-
2008 with 2001-2004 (SAPS II scores and the impact of individual ICUs were adjusted for). 
 
  2001-2004 2005-2008 P 
Age group, yrs     
< 40 Hospital mortality,% 6.3 5.1 0.004 
 
SMR (95% CI) 
Adjusted OR (95% CI) 
0.58 (0.52-0.64) 
Reference 
0.44 (0.40-0.49) 
0.63 (0.53-0.76) 
 
< 0.001 
40-59 Hospital mortality,% 14.5 13.7 0.04 
 
SMR (95% CI) 
Adjusted OR (95% CI) 
0.69 (0.65-0.72) 
Reference 
0.58 (0.55-0.60) 
0.75 (0.69-0.81) 
 
< 0.001 
60-69 Hospital mortality,% 20.1 20.0 0.87 
 
SMR (95% CI) 
Adjusted OR (95% CI) 
0.72 (0.69-0.76) 
Reference 
0.63 (0.61-0.66) 
0.80 (0.73-0.88) 
 
< 0.001 
70-74 Hospital mortality,% 24.5 23.9 0.51 
 
SMR (95% CI) 
Adjusted OR (95% CI) 
0.76 (0.72-0.80) 
Reference 
0.66 (0.62-0.70) 
0.78 (0.70-0.87) 
 
< 0.001 
75-79 Hospital mortality,% 28.6 26.9 0.07 
 
SMR (95% CI) 
Adjusted OR (95% CI) 
0.83 (0.78-0.88) 
Reference 
0.70 (0.67-0.74) 
0.75 (0.67-0.84) 
 
< 0.001 
80- Hospital mortality,% 30.1 31.5 0.17 
 
SMR (95% CI) 
Adjusted OR (95% CI) 
0.80 (0.76-0.85) 
Reference 
0.75 (0.71-0.79) 
0.84 (0.75-0.94) 
 
0.002 
 
 
5.6.2 Influence of Possible Confounding Factors 
 
Influence of new ICUs joining the Consortium 
The observed decrease in severity of illness-adjusted hospital mortality was not caused by new 
ICUs joining the benchmarking programme. When SAPS II scores and the year of admission 
were adjusted for, treatment in departments that joined the Consortium after 2001 was 
associated with increased hospital mortality (adjusted OR for death 1.12, 95% CI 1.07-1.18). 
When only those departments that participated in the Consortium already in 2001 (18 ICUs, 
61,280 patients) were included, the decrease in SMR over time was comparable to that observed 
in the overall patient population: the SMR (95% CI) was 0.73 (0.71-0.75) in 2001-2004 and 0.63 
(0.61-0.64) in 2005-2008.      
 
Influence of changes in hospital discharge practices 
In addition to vital status, the hospital discharge data included information of whether a 
surviving patient was discharged home or to another healthcare institution. Overall, 35.8% of 
the patients (n = 30,594) were discharged from a hospital to another hospital or institutional 
care. This proportion was 37.0% in 2001-2004 and 34.8% in 2005-2008, P < 0.001. For 7 patients, 
the database lacked discharge information. When we excluded from the analyses those patients 
that were discharged to other institutions (leaving 54,946 patients), the SMR (95% CI) was 1.12 
(1.09-1.14) in 2001-2004 and 0.96 (0.94-0.98) in 2005-2008.When SAPS II scores and the impact of 
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individual ICUs were adjusted for, the odds of death were lower in the latter period, adjusted 
OR 0.71 (95% CI 0.67-0.75). 
 
Influence of hospital size 
The odds of death decreased in all hospital groups: when SAPS II scores and the impact of 
individual departments were adjusted for and the period 2001-2004 was the reference, the 
adjusted OR for death in 2005-2008 was 0.87 (95% CI 0.78-0.96, P = 0.005) in small central 
hospital ICUs, 0.73 (95% CI 0.68-0.78, P < 0.001) in large central hospital ICUs and 0.75 (0.70-
0.80, P < 0.001) in university hospital ICUs. When severity of illness, diagnostic categories and 
year of admission were adjusted for and university hospital ICUs made up the reference 
category, treatment in small central hospital ICUs had no independent effect on the risk of 
death (adjusted OR 1.02, 95% CI 0.96-1.08, P = 0.53), whereas treatment in large central hospital 
ICUs was associated with decreased mortality (adjusted OR 0.90, 95% CI 0.86-0.94, P < 0.001). 
 
Data completeness and automation of data collection 
In the overall study population, the median number of missing SOFA parameters was 0 (inter-
quartile range, 0-1). The median number of missing SAPS II physiological parameters was 1 (0-
2). The most commonly missing physiological measurements were the concentrations of 
bilirubin (missing in 46.6% of cases) and urea (missing in 39.3% of cases). These measurements 
are commonly made only when clinically indicated, not just for severity-of-illness scoring. 
Apart from bilirubin and urea concentrations, mean data completeness on other SAPS II 
physiological parameters was 96.6%. Data completeness improved over time. The proportion of 
patients with no missing data on any SAPS II physiological parameters was 26.8% in 2001 and 
49.2% in 2008.  
After adjustments for SAPS II scores, the impact of individual ICUs and the treatment period, 
the binary variable “dataset fully complete on SAPS II physiological parameters” had a 
mathematically independent association with decreased hospital mortality (adjusted OR 0.77, 
95% CI 0.73-0.81). 
A clinical information system (CIS) automatically collects data from patient monitors and the 
hospital’s laboratory systems. Of the 24 participating ICUs, 12 had a CIS installed already at the 
beginning of the study period. 11 ICUs installed a CIS during the study period and one ICU 
continued with manual documentation at the end of 2008. After adjustments for SAPS II scores, 
the impact of individual ICUs and the treatment period, the CIS was independently associated 
with decreased hospital mortality (adjusted OR 0.80, 95% CI 0.73-0.88). 
When severity of illness (SAPS II score) and the impact of individual ICUs were adjusted for, 
treatment in the latter half of the study period (2005-2008), as compared with the period 2001-
2004, was associated with a decreased risk of in-hospital death: adjusted OR (ORTIME) 0.76, 95% 
CI 0.73-0.79. When the documentation-related factors (DRF) “use of CIS” and “number of 
missing SAPS II physiological parameters” were added into the model, the adjusted OR for 
death in the latter period as compared with the early period (ORTIME-DRF) was 0.81, 95% CI 0.78-
0.85. Thus, the relative contribution of the documentation-related factors to ORTIME was 
 
[(1 – 0.76) − (1 – 0.81 )] / [1 – 0.76] = 0.208, i.e. 21%. 
 
This means that after adjustments for SAPS II scores and the impact of individual ICUs but 
without attention paid to documentation-related factors, the odds of death were 24% lower in 
2005-2008 than in 2001-2004. However, five percentage points (i.e. 21%) of this computational 
difference is explained by automated data collection with the use of a CIS and improved data 
completeness. When differences in these factors were also adjusted for, the odds of death were 
19% lower in 2005-2008 than in 2001-2004.   
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The new customised prediction model yielded the following equation: 
 
logit = −9.7618 + 0.03417×(SAPS II score) + 1.6429×[ln(SAPS II score + 1)] + 0.07372×(SOFA score) 
− 0.3939 (only if admission after elective surgery) – 1.7945 (only if admission for diabetic 
ketoacidosis) – 2.0687 (only if admission for drug intoxication) + 0.2416×(number of missing 
SAPS II physiological parameters) – 0.1269 (only if data documented with a CIS)  
 
The probability of in-hospital death was then calculated as  
 
elogit / (1 + elogit).  
 
In the Hosmer and Lemeshow goodness-of-fit test, Ĉ = 14.9 and P = 0.061. The AUC was 0.860 
(95% CI, 0.857-0.863). Hospital mortality rates for each calendar year, adjusted for differences in 
case mix and in documentation with this customised model, and adjusted ORs of death for each 
year are presented in Table 21. The adjusted hospital mortality was 19.4% in 2001-2004 and 
17.5% in 2005-2008. When admission period was added as a variable to the model, the adjusted 
OR for death in 2005-2008 as compared with 2001-2004 was 0.82 (95% CI 0.79-0.86). 
 
Table 21. Adjusted hospital mortality rates and odds ratios for death based on the customised 
prediction model 
 
Year Adjusted hospital  
mortality (%) 
Adjusted OR (95% CI) 
2001 21.1 Reference 
2002 20.4 0.95 (0.86-1.04) 
2003 18.6 0.80 (0.73-0.87) 
2004 18.5 0.79 (0.72-0.87) 
2005 17.9 0.74 (0.68-0.81) 
2006 17.7 0.72 (0.66-0.79) 
2007 17.2 0.69 (0.63-0.75) 
2008 17.3 0.69 (0.63-0.76) 
The adjusted mortality rates were calculated as follows: First, multivariate logistic regression was used to 
develop a model adjusting for differences in case mix and for differences in data collection and to calculate a 
probability of in-hospital death for each patient. The precise equation is presented in the text. For each 
calendar year, the standardised mortality ratio (SMR) was calculated by dividing the observed number of 
deaths by the sum of individual probabilities. Finally, the adjusted mortality rates were calculated for each 
year by multiplying the overall hospital mortality rate (18.35%) by the SMR. The adjusted odds ratios of 
death for each year, compared with the year 2001, were calculated by adding the calendar year as a 
variable to the customised prediction model. 
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6 Discussion  
6.1 IMPACT OF GENDER ON TREATMENT AND OUTCOMES 
Male patients made up 62% of the study population. Quite similar gender distributions have 
been reported in other large studies on heterogeneous ICU populations (Valentin et al. 2003, 
Metnitz et al. 2005, Fowler et al. 2007). The reason for the disproportionately high numbers of 
male patients is unknown. Are males more susceptible to conditions requiring intensive care, or 
is there a bias against admitting females to ICUs? In this study we measured severity of illness 
with APACHE II scores, which were similar between men and women. Thus, it seems that the 
need for intensive care has been assessed irrespective of the patients’ gender. Men have higher 
age-adjusted incidence rates of most severe diseases than women (Jousilahti et al. 1999, Angus 
et al. 2001, Cook et al. 2009), which is probably reflected in the male majority in age groups 
other than the oldest group, where females made up the majority. 
Even if there were a causal relationship between some factor and the critical illness that 
requires treatment in an ICU, that factor would not necessarily prove to be an independent 
predictor of poor outcome when the population studied consists only of patients that have 
already been admitted to ICUs. In the overall study population of ICU patients, gender had no 
impact on outcome. However, male gender was associated with increased hospital mortality 
among postoperative patients and in the oldest age group.  
Male patients were treated longer than female patients. Even after adjustment for severity of 
illness, the mean length of stay was higher for men than for women both overall and within 
most diagnostic categories. These results together with the higher risk of death of male patients 
in certain subgroups imply that women may have a better ability than men to recover from 
critical illness or surgery. 
In some previous large studies, outcomes of men have not been worse than outcomes of 
women (Valentin et al. 2003, Fowler et al. 2007). However, in these studies, proportionately 
more men than women were admitted to ICUs after cardiovascular surgery, which is a 
diagnostic group with a relatively good prognosis. The possible effects of different diagnostic 
categories were not adjusted for. 
The reasons for gender-based differences are not evident. Sex hormones (Bouman et al. 2005), 
other hormonal mechanisms (Van den Berghe et al. 2000) and the cellular mosaicism of X-linked 
genes in females (Spolarics 2007) may play some role. Most probably behavioural factors, 
smoking and heavy alcohol use in particular, are also important. The need of intensive care is 
often related to alcohol use, and this particularly affects males (Uusaro et al. 2005). Whatever 
the reasons behind the differences, this study supports the conclusion of Edgar V. Allen (1934): 
“The male is fundamentally the weakling of the two sexes.” 
If the differences between genders in outcome were caused primarily by sex hormones, one 
would expect these differences to be more pronounced in people of premenopausal age. This 
hypothesis is supported by the study of Wohltmann et al. (2001), in which young women 
seemed to have a survival advantage when compared with equally injured young men, 
whereas outcome was not gender-related in patients older than 50 years. In our study, however, 
male gender was associated with an increased risk of death in patients aged 75 years or older 
but not in the younger age groups. It is possible that men in the oldest age group have a higher 
incidence of concomitant cardiovascular disease or chronic pulmonary disease and thus a 
higher risk of cardiovascular or pulmonary complications than women.  
In the study by Valentin et al. (2003), men received an increased level of care and had a 
higher probability of receiving several invasive procedures. In our study, the intensity of care 
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was higher for men than for women in the overall study population. However, the diagnostic 
category “vascular surgery” comprised a higher proportion of men than women. Patients in this 
category were treated more intensively than patients of other diagnostic categories. This fact 
explains most of the difference found between genders in intensity of care. When severity of 
illness and the effects of different diagnostic categories were adjusted for, the difference 
between genders was small. Moreover, there were only insignificant differences between 
genders in the intensity of care within most diagnostic categories. These results do not support 
the hypothesis that a patient’s gender would influence the intensity of ICU care in Finland.  
6.2 SEASONAL VARIATIONS IN MORTALITY 
The winter season is associated with excess mortality in the general population due to an 
increased incidence of myocardial infarctions, strokes and respiratory problems (Sheth et al. 
1999, Keatinge 2002, Olson et al. 2009). Some authors attribute the extra deaths to cold stress 
(Keatinge 2002), others to influenza epidemics (Reichert et al. 2004). In this study, hospital 
mortality of patients treated in Finnish ICUs was higher in winter than in other seasons.  
Conditions inside the walls of an ICU remain rather constant regardless of season-related 
changes in conditions outdoors. Thus, one would not expect severity of illness-adjusted 
outcomes to vary much between different seasons. In this study, the independent effect of the 
winter season was non-significant when each diagnostic category was analysed separately, 
which means that outcomes of patients with a given severity of disease were not worse in the 
winter season. However, there was a higher amount of seriously ill patients needing intensive 
care for respiratory failure in winter than in other seasons and this led to extra deaths in winter. 
These findings are in accordance with the results of Danai et al. (2007). They analysed 
hospital discharge data on over 12 million patients that were hospitalised because of sepsis in 
the USA in 1979-2003 and found that both the incidence and mortality of sepsis are seasonal and 
consistently highest during winter. The seasonal variability is mainly related to respiratory 
sepsis. 
In this study, the proportion of patients aged 75 years or older was higher in winter than in 
other seasons. This partly explains the higher crude mortality rates in winter. The finding 
implies that winter increases old people’s susceptibility to conditions requiring intensive care.  
“The July phenomenon” refers to the idea that the quality of medical care might be 
substandard in July. However, according to previously published studies, this phenomenon 
seems to be fiction rather than fact, at least in intensive care (Barry and Rosenthal 2003, 
Finkielman et al. 2004). Our study found similar results: Crude hospital mortality was higher in 
July than in other months, but this difference seems to be entirely explained by differences in 
case mix, the most important of which is the lower amount of patients admitted after scheduled 
surgery in July. After differences in case mix were adjusted for, outcomes of patients treated in 
July were not different from outcomes of patients treated in other months.  
An increase in the mean daily TISS score was an independent predictor of increased hospital 
mortality. This finding is not surprising: the mean daily TISS score reflects the intensity of the 
care needed in the particular case and thus is a measure of the severity of illness. Some previous 
studies have shown that high TISS scores at the time of discharge from the ICU mean an 
increased risk of death after intensive care (Smith et al. 1999, Beck et al. 2002). Our findings 
agree well with these previous results: patients needing care of high intensity are at a high risk 
of death. 
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6.3 INFLUENCE OF OLD AGE 
This study showed that old age is indeed a risk factor for death: with a given severity of illness, 
old patients have a far higher risk of in-hospital death than younger patients. Particularly the 
oldest patients admitted for medical reasons are at a high risk of death, as are those elderly 
patients whose ICU stay is long. These findings are in accordance with the results of a large 
study from Australia and New Zealand: old age, non-surgical admission, greater illness 
severity, and prolonged stay in the ICU are associated with poor outcomes (Bagshaw et al. 
2009). In our study, the hospital mortality rate seemed to rise in quite a linear way with 
increasing age. However, elderly women seem to be less sensitive than elderly men to the 
effects of further aging: the impact of one additional year of age on risk of death was smaller 
among elderly women than men.  
Among the youngest patients, deaths after intensive care, during the same hospitalisation, 
were rather uncommon. Among the oldest patients, even more deaths occurred after intensive 
care than in the ICU. This may reflect the limited ability of many elderly patients to recover 
from serious illnesses. It has been shown previously that elderly trauma patients are more likely 
than younger patients to die later because of the combination of injury and pre-existing diseases 
and complications (Perdue et al. 1998). The high amount of post-ICU deaths is probably also 
associated with restrictions of future care because further aggressive treatment is considered to 
be futile. Restrictions (which may include for example orders not to attempt resuscitation or the 
refusal of a new ICU admission) were quite often imposed on the oldest patients. 
The mean intensity of care was at its highest among patients aged 60-79 years. Younger 
patients as well as the oldest patients were treated less aggressively. However, in the youngest 
age groups also the mean severity of illness was at its lowest, whereas the severity of illness was 
at its highest in the oldest age group. It seems that the care of the oldest patients has been 
notably limited. The data about lengths of ICU stay support the same conclusion: the length of 
stay was at its highest in the age group 75-79 years, but markedly shorter for patients aged 80 
years or over. It seems that the average Finnish ICU keeps on treating ageing patients with full 
intensity until approximately 80 years of age, after which the mean intensity declines. That said, 
it should be noted that even in the oldest age group, a significant proportion of patients 
received treatment of high intensity. In particular, the use of several vasoactive drug infusions 
was even more common in the oldest age group than among younger patients.  
Withdrawal of aggressive life-sustaining therapy is generally considered appropriate in a 
situation where the patient’s condition deteriorates despite active treatment and the prognosis 
gives no hope for recovery (Chelluri et al. 1995). At times, the right decision is to not even start 
aggressive treatments that would be futile (Ely 2003). However, a major problem in the 
intensive care of severely ill elderly people is to reliably identify those patients for whom 
therapy is futile. It is incorrect to restrict therapeutic activity in all old patients. Even after 
prolonged intensive care, a reasonable proportion of elderly patients survive. Most elderly 
survivors consider their quality of life as satisfactory or good a few years after ICU discharge 
(Kaarlola et al. 2006, Roch et al. 2011).  
The mean length of ICU stay was at its longest in the age group 75-79 years and the mean 
intensity of care was also high in this age group. Still, the hospital mortality rate was rather 
high, namely 24%. Thus, a relatively high amount of ICU resources was consumed in relation to 
the number of surviving patients. The cost of one life saved was almost double in the age group 
75-79 years as compared with the youngest age group. Given the relatively low life expectancy 
of people over 75 years old, the cost of life years gained becomes much higher than in younger 
age groups. On the other hand, the amount of resources consumed per one survivor was rather 
low in the oldest age group.  
An important question is whether intensive care resources are used correctly in the treatment 
of old patients. Many elderly patients do benefit from intensive care. On the other hand, ICU 
services may be superfluous. According to a study from Sweden, reduction of intensive care 
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resources because of cost containment in the 1990s led to shorter lengths of ICU stay and lower 
TISS scores for elderly patients without any significant change in 180-day mortality (Walther 
and Jonasson 2004). According to the authors, ICU services were probably over-dimensioned 
during the early years of the study period. Among the ICUs in our study, the proportion of 
patients aged 80 years or older varied a lot, from 3% to 18%. A major reason for these 
differences probably lies in the character of the individual departments and hospitals: in some 
hospitals, there are relatively many ICU beds but otherwise relatively few high-dependency 
beds. However, the magnitude of the differences suggests that there may be differences 
between hospitals within Finland in treatment strategies regarding the oldest old patients. 
Based on this study, it is not possible to estimate what an ideal proportion would be. 
Nevertheless, these differences give reason to speculate that in some hospitals equally good 
outcomes might be achieved with less intensive treatment and with less costs, whereas in other 
hospitals there may have been patients who might have benefited from more aggressive 
therapy.  
The ageing of the population will most probably increase the demand for intensive care in 
the near future. Projections based on studies in other countries anticipate an even larger 
increase in the demand for ICU services (Needham et al. 2005, Laake et al. 2010). The difference 
in forecasts is mainly caused by the differences in projections for population growth, which is 
predicted to be very low in Finland. Otherwise the results of this study are in agreement with 
the forecasts based on other studies. The baby boom generation of the post-war years is 
approaching the years of life most commonly associated with the need for intensive care, 
causing a substantial increase in the need for ICU resources. 
6.4 THE RELATIONSHIP BETWEEN HOSPITAL SIZE AND OUTCOMES  
In the overall population of ICU-treated adult patients with severe sepsis, there were no 
statistically significant differences between university and non-university hospital ICUs or 
between large and small ICUs in unadjusted hospital mortality rates. However, after 
adjustment for severity of illness, treatment in small central hospital ICUs as compared with 
large ICUs was associated with an increased risk of death. The mortality of postoperative 
patients was higher for small ICUs than for large ICUs. Mortality rates were especially high 
among patients with long lengths of stay in small ICUs.  
The number of patients in our study was rather small. Further studies are needed to find the 
patient groups that would benefit from treatment in large hospitals. Our results are however in 
concordance with some previous studies suggesting that higher patient volumes are associated 
with better outcomes in intensive care (Kahn et al. 2006, Peelen et al. 2007). That said, one has to 
bear in mind that the literature on this topic is controversial: several studies have found no 
evidence for a volume-outcome relationship (Engel et al. 2007, Gopal et al. 2011, Nguyen et al. 
2011).  
When a relationship between higher patient volumes and improved outcomes has been 
found, a common explanation has been that a higher number of patients gives the staff more 
experience, which may benefit subsequent patients. Another plausible explanation is that high-
volume centres may be better at adopting new useful therapies or more probably have in place 
organisational factors that are associated with improved outcomes (Kahn 2007b). One such 
factor that may improve patient outcomes is the availability of multidisciplinary expertise. 
Rothen et al. (2007) defined a very efficient unit as one with both a low standardised mortality 
ratio and low standardised resource use. The presence of multiprofessional clinical rounds was 
associated with the probability of an ICU belonging to the group of most efficient units.   
The need for multidisciplinary expertise may be a problematic issue in many small Finnish 
hospitals, especially during out-of-office hours. Broad expertise, e.g. in the different specialities 
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of surgery, may not be continuously available. In this study, treatment in small central hospital 
ICUs was associated with a worse outcome in surgical but not in medical patients. Severely ill 
surgical patients often need experts from several specialities (e.g. radiology, gastroenterological 
surgery, anaesthesiology and intensive care medicine) to get the right diagnosis and adequate 
treatment. One might speculate that surgical patients may be more vulnerable than medical 
patients to the limited availability of expertise in small hospitals. 
According to Kahn (2007b), regionalisation of critical care may be the best solution when a 
volume-outcome relationship exists and the reasons behind it are related to organisational 
factors not easily exportable to small units. However, regionalisation of medical care may also 
have drawbacks. Already more than 25 years ago, Luft (1985) and Maerki et al. (1986) 
recommended regionalisation of many surgical procedures to high-volume hospitals, but also 
highlighted some problems potentially resulting from regionalisation of care: In small hospitals, 
it might lead to situations where medical services urgently needed for emergencies are not 
available. For some procedures or diagnoses, regionalisation of care to distant hospitals may not 
be feasible because of the emergency nature of the problem. 
Results from studies done in densely populated urban areas and recommendations based on 
these studies do not necessarily apply to rural areas. According to Luft (1985), “In the US, many 
hospitals within sight of each other often provide the same services.” In California, 58% of patients 
treated in low-volume hospitals could have gone to a high-volume hospital without having to 
travel more than 16 km (10 miles) farther and 76% could have reached a high-volume hospital 
without having to travel more than 40 km (25 miles) farther (Dudley et al. 2000). Obviously, the 
situation is different in sparsely populated Finland. Thus, both study results and local 
circumstances should be considered when regionalisation of care is discussed. 
6.5 THERAPEUTIC HYPOTHERMIA FOR POST-RESUSCITATION CARE  
Survival of out-of-hospital cardiac arrest (OHCA) patients treated in Finnish ICUs was better in 
2003-2008 than in 2000-2002. This finding was consistent for both younger and older patients 
and for both genders. A plausible explanation for this improvement in outcome is the use of 
therapeutic hypothermia (TH), which became widespread in Finland after publication of the 
studies by Bernard et al. (2002) and the Hypothermia after Cardiac Arrest Study Group (2002).  
The improvement in outcome took place concurrently with the implementation of TH in 
most Finnish ICUs, supporting the interpretation that TH is the main reason for the 
improvement. Regarding changes in other treatments, tight glycaemic control with intensive 
insulin therapy has to be considered as a potential confounding factor, as it became common at 
about the same time, after Van den Berghe et al. (2001) published positive results of this 
treatment in surgical patients. However, later studies have failed to show a reduction in 
mortality of medical patients with intensive insulin therapy (Van den Berghe et al. 2006, NICE-
SUGAR Study Investigators 2009). As the usefulness of tight glycaemic control is questionable 
(Marik and Varon 2007), it is unlikely that implementation of intensive insulin therapy would 
explain the results of our study.  
A recent study from the Netherlands showed a significant reduction in hospital mortality of 
ICU-treated cardiac arrest patients after implementation of TH (van der Wal et al. 2011). The 
crude hospital mortality rates were higher (72.0% before TH, 65.4% after implementation of TH) 
than in our study, but so was the mean severity of illness as reflected by the SAPS II scores. The 
absolute risk reduction achieved after implementation of TH (6.6%) was of the same magnitude 
as in our study (6.8%). These figures correspond to a number needed to treat (NNT) of around 
15. 
A study from Sweden found a significantly improved survival of patients resuscitated from 
ventricular fibrillation in 2003-2006 as compared with 1980-2002: one-year survival 57% vs. 37% 
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(Martinell et al. 2010). However, the percentage of patients whose initial rhythm was 
ventricular fibrillation decreased during the study period and for all patients resuscitated from 
OHCA, there was no statistically significant change in survival.  
We found that an improvement in outcome took place in 2003 and it has persisted ever since. 
However, although the use of TH has increased even after 2003, there seem to have been no 
further improvements. According to a survey (Oksanen et al. 2007), TH was at first used in 
Finland almost exclusively for patients resuscitated from ventricular fibrillation, and the 
inclusion criteria of the HACA trial (Hypothermia after Cardiac Arrest Study Group 2002; the 
criteria also presented in chapter 2.6.2 of this thesis) were used to select patients for the 
treatment. In this study we found that over the years TH was given to more severely ill patients. 
This is in accordance with the fact that many ICUs no longer strictly stick to the HACA trial’s 
inclusion criteria. It seems possible that patients fulfilling these criteria are the ones most likely 
to benefit from TH and loosening the criteria for patient selection brings little additional benefit. 
This view is supported by the results of two newly published studies that found no benefit of 
TH in patients resuscitated from cardiac arrest with a non-shockable initial rhythm (Dumas et 
al. 2011, Storm et al. 2012). Nevertheless, it is still possible that sporadic resuscitated patients 
may benefit from TH although the initial rhythm was non-shockable. Based on this idea and on 
the fact that harm caused by TH is usually manageable, current Scandinavian guidelines 
recommend TH for all comatose resuscitated patients, if active treatment is considered 
justifiable (Castrén et al. 2009). 
Lengths of ICU stay were longer in 2003-2008 than in 2000-2002. This change is explained by 
the relatively long lengths of stay of patients treated with TH. We also found an increase in 
intensity of care. It seems that the overall approach towards post-resuscitation patients has 
become more active. Considerably more resources were used in the treatment of patients 
resuscitated from cardiac arrest in 2003-2008 than in previous years. 
In many countries that there are published reports from, implementation of TH for post-
resuscitation care has been quite slow (Laver et al. 2006, Wolfrum et al. 2007, Bianchin et al. 
2009). In addition to obstacles caused by resource issues, unawareness of the level of evidence 
regarding the usefulness of the treatment or lack of consensus about it have been mentioned as 
common reasons for not using TH in the UK (Laver et al. 2006). There have even been outbursts 
of scepticism in recent years (Fisher 2008). In 2007, the vast majority of Italian ICUs were not 
using TH (Bianchin et al. 2009). The two most common reasons for this were “No experience, need 
more info” and “Never thought about it”.  
In Finnish ICUs, TH was promptly implemented. A certain author once considered the love 
of progress as typical of the Finns: In the 1890s, Ángel Ganivet was the Spanish consul in 
Finland, at that time the Grand Duchy of Finland, an autonomic part of the Russian Empire. He 
wrote, “The enthusiasm with which all innovations of practical utility are accepted, and the speed and 
perfection with which they are assimilated, are characteristic of Finland” (Ganivet 1905). 
6.6 THE NATIONAL BENCHMARKING PROGRAMME: THE FINNISH 
INTENSIVE CARE CONSORTIUM 
During the years 2001-2008, the mean hospital mortality rate for patients treated in Finnish 
ICUs, cardiac surgical patients excluded, was 18.4%. Based on severity scores, the mean severity 
of illness in this study population was comparable to the mean severity of illness in a large 
study from the UK (Harrison et al. 2004b) and to that in the multinational SAPS 3 study 
(Metnitz et al. 2005). Despite this, mean hospital mortality rates were considerably higher both 
in the UK (28.6%) and in the SAPS 3 study (28%). Based on these figures, it can be concluded 
that the outcomes of Finnish intensive care patients are rather good. 
65 
 
 
Moreover, outcomes improved during the study period: both the crude hospital mortality 
rate and severity of illness-adjusted mortality decreased. Outcomes improved in all age groups, 
for all admission types and in both small and large hospitals. The impact of new departments 
joining the benchmarking programme did not explain the improvements.   
Though hospital mortality is commonly used as an outcome measure, it may be problematic. 
Patients discharged to other institutions are calculated as hospital survivors. However, some of 
these patients will die within the following months. Thus, discharges to other hospitals or 
institutional care may cause bias (Kahn et al. 2007a). It has been recommended that mortality at 
a fixed time point such as 30-day or 90-day mortality should be substituted for hospital 
mortality (Glance and Szalados 2002). For situations where only hospital mortality is available, 
Angus (2000b) has suggested doing analyses with and without patients discharged to long-term 
and rehabilitation facilities. We did this and found that the observed decrease in SMRs over the 
years cannot be attributed to changes in hospital discharge practices.  
The more abnormal the values of physiological measurements, the more points are given to 
severity-of-illness scores. When data are missing, the values of the parameters in question are 
presumed to be within the normal range. Thus, patient populations with many incomplete 
datasets may appear less severely ill than they actually are. Consequently, improving data 
completeness might lead to an increase in mean severity of illness and thus a decrease in SMRs. 
Data completeness improved during the study period and this does partly explain the observed 
improvements in SMRs.  
Automation of data collection with a CIS increases the sampling rate of physiological data. 
This increases the probability of obtaining abnormal values and thus leads to higher severity-of-
illness scores and lower SMRs, which has been confirmed in previous studies (Bosman et al. 
1998, Suistomaa et al. 2000). In this study, the use of a CIS had an independent mathematical 
association with decreased severity of illness-adjusted mortality. The severity-adjusted odds of 
death were 24% lower in 2005-2008 than in 2001-2004, but roughly one fifth of this difference 
between the admission periods is explained by automated data collection with the use of a CIS 
and improved data completeness.  
We developed a new customised prediction model that takes into account both differences in 
case mix and differences in documentation-related factors (i.e. the use of a CIS and the number 
of missing SAPS II physiological parameters). The goodness of fit of this model was satisfactory, 
as was the discrimination. Based on this model, the adjusted mortality rate decreased from 
21.1% in 2001 to 17.3% in 2008. If a difference of this magnitude were achieved with some new 
intervention, then the corresponding number needed to treat (NNT) would be around 26. 
This means that outcomes improved considerably over the years. Most probably, genuine 
improvements in the quality of intensive care have taken place. It is also possible that patient 
selection may have improved: ICUs may have learnt to better allocate intensive care to patients 
that are able to benefit from aggressive treatment. Based on this study, it is not possible to 
answer the question whether the improved outcomes can be attributed to the benchmarking 
programme per se. According to lessons learnt from manufacturing industries, an essential step 
in striving for quality improvements is measuring the results of one’s processes. Moreover, as 
David T. Kearns, former CEO at the Xerox Corporation, put it, “Quality improvement can’t be 
measured in a meaningful way against standards of your own internal devising” (Kearns 1990.) This 
study shows that outcomes have improved concurrently with the benchmarking programme. 
However, as there was no control group in the study, it is not possible to prove any causality 
between the programme and the changes in outcomes. 
Nevertheless, the benchmarking programme has had an impact in the generation of a 
network of communication and of collaboration within the Finnish intensive care community, 
which in turn has influenced the harmonisation of clinical practices and the implementation of 
treatments proven to be beneficial. This may have had a positive effect on the quality of care.  
This study confirms that improving data completeness and automation of data collection do 
decrease severity-adjusted mortality rates. This should be taken into consideration in 
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benchmarking programmes if some ICUs use technology for automatic data collection and 
others do not. In Finland, this issue has no longer any major significance as a confounding 
factor, because a CIS for automated data collection is used in practically all ICUs. 
6.7 LIMITATIONS OF THE STUDY 
The main strength of this study is the high number of patients and rather good data 
completeness. The study populations represent well the patients treated in Finnish ICUs. There 
are some important limitations, though. The main weaknesses of this study are those that are 
inherent in retrospective studies. A mathematical association between two factors does not 
necessarily prove any causal relationship, as it may be impossible to completely control for all 
potential confounding factors. 
There were no uniform criteria for ICU admission. Admission depended on the decision of 
the attending physicians, and the availability of other high-dependency units has also had some 
impact. Thus, there was heterogeneity between ICUs and also changes over time. Severity 
scores were used to adjust for differences in case mix, but it is well known that no severity-of-
illness model is perfect in controlling for these differences (Moreno and Afonso 2008). In 
addition to severity scores, we also adjusted for the impact of different diagnostic categories. 
However, category grouping is not always unambiguous. 
For each patient treated in an ICU participating in the Finnish Intensive Care Consortium, 
vital status at hospital discharge is registered into the Consortium’s database. For 
comprehensive follow-up even after that, registering the personal identity number of each 
patient would be necessary. That is possible in Finland only if consent is obtained 
prospectively. Thus, only data on hospital mortality were available for studies I-III and V-VI. 
The lack of data on fixed-time mortality is a shortcoming but it does not invalidate the main 
findings of the studies. Efforts to improve long-term follow-up have already been made in the 
Consortium. 
In Study III, severity of illness was measured with the SAPS II scoring system, which does 
not take into account most chronic diseases nor the functional status of the patient. The lack of 
adjustment for these factors may have influenced the impact of chronological age on prognosis, 
most probably leading to an overestimation of the influence of age. On the other hand, it is 
possible that very severely ill old patients may have been refused ICU admission more often 
than younger patients because of a gloomy prognosis and the subsequent assumption that 
intensive care would be futile. This in turn would lead to an underestimation of the impact of 
old age on the risk of death.  
The major weakness of Study IV is the low number of patients. Therefore the results should 
be interpreted with caution. Another limitation is that the definitions of “small” and “large” 
ICUs may be regarded as somewhat arbitrary. The units classified as “large” in this study might 
be classified as small somewhere else.  
There are also several limitations to Study V. The Consortium’s database contains no 
information about the initial cardiac rhythm of the cardiac arrest patient, nor about the quality 
and length of resuscitation. Some changes may have taken place in these factors during the 
study period. In addition, we know nothing about patients that may have been taken alive to 
hospital but not admitted to the ICU. However, it is not likely that any major changes occurred 
in pre-hospital factors or in ICU admission policies between the years 2002 and 2003. Thus it is 
unlikely that a change in patient characteristics would account for the observed improvement in 
hospital mortality rates. Another important limitation is that we do not have information about 
the neurological outcomes of survivors.  
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6.8 IMPLICATIONS AND FUTURE PERSPECTIVES 
Male gender is a risk factor for conditions requiring intensive care. It also increases the risk of 
poor outcome in some groups of ICU patients. More studies are needed to fully understand the 
reasons for this. However, the gender-based differences are probably caused partly by genetic 
and partly by behavioural factors, of which alcohol consumption is of importance (Uusaro et al. 
2005). Factors that are effective in reducing excessive use of alcohol would probably also result 
in a decrease in untimely ICU admissions and deaths. Sex hormones also influence the 
resistance to severe infections (Bouman et al. 2005). However, all too little is known about their 
effects, and based on current knowledge no sex hormone treatments of severely ill patients can 
be proposed. 
There is excess mortality in intensive care patients in the winter season. Severe respiratory 
failure is more frequent in winter than in other seasons. This should be taken into consideration 
when resource allocation is planned. Mortality is increased in winter also in the general 
population, which has been attributed to cold stress (Keatinge 2002) and influenza epidemics 
(Reichert et al. 2004). Avoiding harmful cold exposure with adequate clothing and indoor 
heating in conjunction with vaccination programmes and antiviral therapy against influenza are 
probably the most effective means of fighting against the winter-related risk of death. 
Because of a reduced number of elective surgical patients during the holiday season, the case 
mix of Finnish ICU patients in July is different from that in other months. Crude mortality is 
increased in July, but the severity of illness-adjusted risk of death is not increased. It seems that 
the ICUs can keep their performance at a good level also during the holiday season.  
The risk of death of intensive care patients increases in quite a linear way with increasing 
age. Particularly the oldest patients admitted for medical, i.e. non-surgical reasons are at a high 
risk of death, as are those elderly patients whose ICU stay is prolonged. Nevertheless, even in 
the oldest age group a reasonable proportion of patients survive after intensive care. Previous 
studies have shown that most elderly survivors consider their quality of life as satisfactory or 
good (Kaarlola et al. 2006, Roch et al. 2011). This means that intensive care is worthwhile also 
for many old patients. 
Future studies are needed to learn more about long-term outcomes of severely ill old patients 
in various diagnostic groups. Being able to identify the patients that can benefit from aggressive 
treatment and those for whom intensive care is futile will be increasingly important in the years 
to come, as the ageing of the population will substantially increase the number of elderly people 
in society and also increase the demand for intensive care.  
For surgical patients with severe sepsis, outcomes were worse in small ICUs than in large 
ICUs. However, because of the rather small number of patients in Study IV, this result must be 
interpreted with caution. Further studies are needed to explore the relationship between 
hospital volumes and patient outcomes and to identify those patients that might benefit from 
regionalisation of care to large hospitals. 
Despite evidence-based international guidelines (Nolan et al. 2003), implementation of TH 
for post-resuscitation care has been slow in many countries. This study showed that 
concurrently with the implementation of TH, hospital mortality of patients treated in Finnish 
ICUs after resuscitation from out-of-hospital cardiac arrest decreased. Hopefully these results 
together with comparable results from other studies (van der Wal et al. 2011) will encourage 
hesitant ICU leaders to implement this treatment in their departments.  
However, there are still unanswered questions regarding TH. There is uncertainty about the 
usefulness of the treatment in patients resuscitated from non-shockable initial rhythms 
(asystole, pulseless electrical activation) and about the optimal target temperature, timing and 
duration of cooling (Sunde and Søreide 2011). More research is needed to find the answers.  
Hospital mortality rates of Finnish ICU patients are rather low compared to results of 
international studies. Moreover, the outcomes of Finnish intensive care have further improved 
during the years 2001-2008. However, we should beware of self-satisfaction because there is still 
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plenty of room for improvements. A major shortcoming in the benchmarking programme of the 
Finnish Intensive Care Consortium is the lack of comprehensive long-term follow-up. The true 
benefits of intensive care can only be measured when long-term outcomes are known. Many 
hospitals have already made efforts to improve in this respect. This should be seen as a key 
factor for development in the Consortium. 
Improved data completeness and automation of data collection increase severity-of-illness 
scores and thus decrease standardised mortality ratios. It is advisable that this should be taken 
into consideration in benchmarking programmes in other countries, if some ICUs use 
technology for automatic data collection and others do not.  
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7 Conclusions  
Based on these studies, the following conclusions can be drawn: 
 
1) Males make up a majority of ICU patients. Male gender is associated with increased hospital 
mortality among post-operative patients and in the oldest age group. Lengths of ICU stay are 
longer for men than for women. 
 
2) Because of a high amount of patients suffering from respiratory failure in winter, there is 
excess hospital mortality in intensive care patients in the winter season. The severity of illness-
adjusted risk of death is not higher in July, the main holiday season, than in other months. 
 
3) The risk of death of intensive care patients increases with increasing age. Mortality is 
particularly high among the oldest patients admitted for medical reasons and among those 
elderly patients whose ICU stay is prolonged. The intensity of care is lower for the oldest 
patients than for patients aged less than 80 years.  
 
4) For surgical patients with severe sepsis, treatment in small ICUs was associated with 
increased hospital mortality. Because of the small sample size, further studies are needed to 
confirm or refute this association. 
 
5) For patients treated in Finnish ICUs after resuscitation from out-of-hospital cardiac arrest, 
hospital mortality decreased concurrently with the implementation of therapeutic hypothermia. 
 
6) Outcomes of Finnish intensive care patients are rather good. The outcomes further improved 
during the years 2001-2008. Improved data completeness and automation of data collection 
with a clinical information system do decrease severity of illness-adjusted mortality rates. 
However, this explains only one fifth of the improvement in measured outcomes in recent 
years. 
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Appendix  
INTENSIVE CARE UNITS THAT WERE PARTICIPATING IN THE FINNISH 
INTENSIVE CARE CONSORTIUM AT THE END OF THE STUDY PERIOD (IN 
ALPHABETICAL ORDER):  
 
The number of beds refers to the situation in 2005.  
 
Hospital Number of beds 
In the Finnish 
Intensive Care 
Consortium from 
Helsinki University Central Hospital, Jorvi Hospital, 
Espoo 8 1998 
Helsinki University Central Hospital, Meilahti Hospital, 
Helsinki (three departments) 9 + 8 + 10 2002, 2003, 2004 
Kainuu Central Hospital, Kajaani 8 1998 
Kanta-Häme Central Hospital, Hämeenlinna 5 1998 
Keski-Pohjanmaa Central Hospital, Kokkola 4 2000 
Keski-Suomi Central Hospital, Jyväskylä 8 1994 
Kuopio University Hospital, Kuopio 15 2000 
Kymenlaakso Central Hospital, Kotka 5 2000 
Lappi Central Hospital, Rovaniemi 8 1999 
Länsi-Pohja Central Hospital, Kemi 5 2007 
Mikkeli Central Hospital, Mikkeli 5 1994 
North Karelia Central Hospital, Joensuu 8 1994 
Oulu University Hospital, Oulu (two departments) 10 + 10 2000 
Päijät-Häme Central Hospital, Lahti 8 1994 
Satakunta Central Hospital, Pori 8 1994 
Savonlinna Central Hospital, Savonlinna 6 1994 
Seinäjoki Central Hospital, Seinäjoki 7 1994 
South Karelia Central Hospital, Lappeenranta 6 1994 
Tampere University Hospital, Tampere 18 2002 
Turku University Central Hospital, Turku 22 2002 
Vaasa Central Hospital, Vaasa 10 1998 
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